Литература

1. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines forthe Clinical Use of Cardiac Radionuclide Imaging). Circulation2003; 108:1404 –18. 2. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003; 42:954 –70. 3. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159–68. 4. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/ SCAI guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1–121. 5. Leatham A. Systolic murmurs. Circulation 1958; 17:601–11. 6. Braunwald E, Perloff JK. Physical examination of the heart and circulation. In: Zipes DP, Libby P, Bonow RO, Braunwald E, Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition. Philadelphia, PA: Elsevier, 2005:77. 7. Shaver JA, Salerni R. Auscultation of the heart. In: The Heart. NewYork, NY: McGraw-Hill, 1994:253–314. 8. O’Rourke RA, Braunwald E. Physical examination of the cardiovascular system. In: Principles of Internal Medicine. New York, NY: McGraw-Hill, 1998:1231–7. 9. Shaver JA. Cardiac auscultation: a cost-effective diagnostic skill. Curr Probl Cardiol 1995; 20:441–530. 10. Karliner JS, O’Rourke RA, Kearney DJ, Shabetai R. Haemodynamic explanation of why the murmur of mitral regurgitation is independent of cycle length. Br Heart J 1973; 35:397– 401. 11. Lembo NJ, Dell’Italia LJ, Crawford MH, O’Rourke RA. Diagnosis of leftsided regurgitant murmurs by transient arterial occlusion: a new maneuver using blood pressure cuffs. Ann Intern Med 1986; 105:368 –70. 12. Grewe K, Crawford MH, O’Rourke RA. Differentiation of cardiac murmurs by dynamic auscultation. Curr Probl Cardiol 1988; 13:669–721. 13. Lembo NJ, Dell’Italia LJ, Crawford MH, O’Rourke RA. Bedside diagnosis of systolic murmurs. N Engl J Med 1988; 318:1572– 8. 14. Marriott H.J.L. Bedside Cardiac Diagnosis. Lippincott, Philadelphia,PA: 116 1993;318:1572– 8. 15. Harvey WP. Cardiac pearls. Dis Mon 1994; 40:41–13. Литература 16. Yoshida K, Yoshikawa J, Shakudo M, et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 1988; 78:840 –7. 17. Smythe JF, Teixeira OH, Vlad P, Demers PP, Feldman W. Initial evaluation of heart murmurs: are laboratory tests necessary? Pediatrics 1990; 86:497–500. 18. Xu M, McHaffie DJ. Nonspecific systolic murmurs: an audit of the clinical value of echocardiography. N Z Med J 1993; 106:54–6. 19. Sahn DJ, Maciel BC. Physiological valvular regurgitation: Doppler echocardiography and the potential for iatrogenic heart disease. Circulation 1988; 78:1075–7. 20. Choong CY, Abascal VM, Weyman J, et al. Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography. Am Heart J 1989; 117:636–42. 21. Klein AL, Burstow DJ, Tajik AJ, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr 1990; 3:54–63. 22. Fink JC, Schmid CH, Selker HP. A decision aid for referring patients with systolic murmurs for echocardiography. J Gen Intern Med 1994; 9:479–84. 23. Abrams J. Essentials of Cardiac Physical Diagnosis. Philadelphia, PA: Lea & Febiger, 1987. 24. O’Rourke RA. Heart murmur. In: Primary Cardiology. WB Saunders Co., 1998. 25. Northcote RJ, Knight PV, Ballantyne D. Systolic murmurs in pregnancy: value of echocardiographic assessment. Clin Cardiol 1985; 8:327– 8. 26. Mishra M, Chambers JB, Jackson G. Murmurs in pregnancy: an audit of echocardiography. BMJ 1992; 304:1413– 4. 27. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with twodimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16:777– 802. 28. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation 1997; 96:358–66. 29. Deleted per 2008 Focused Update. 30. Bansal RC. Infective endocarditis. Med Clin North Am 1995; 79: 1205–40. 31–42. Deleted per 2008 Focused Update. 43. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167–71. 44. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325:783–93. 45. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995; 96:758–64. 46. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med 1987; 317:91– 8. 47. Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum Pathol 1993; 24:1330–8. 294 295 48. Stephan PJ, Henry AC III, Hebeler RF Jr, Whiddon L, Roberts WC. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol 1997; 79:166 –72. 49. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920 –5. 50. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23:1162–70. 51. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of “degenerative” valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994; 90:844 –53. 52. O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16:523–32. 53. Mohler ER III, Chawla MK, Chang AW, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999; 8:254–60. 54. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low-density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19:1218 –22. 55. Ghaisas NK, Foley JB, O’Briain DS, Crean P, Kelleher D, Walsh M. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement.J Am Coll Cardiol 2000; 36:2257– 62. 56. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001; 103:1522– 8. 57. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 2001; 10:371– 4. 58. O’Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensinconverting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002; 106:2224–30. 59. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 2002; 88:348 –51. 60. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003; 107:2181–4. 61. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95:2262–70. 296 62. Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB. Adaptations of the left ventricle to chronic pressure overload. Circ Res 1976; 38:172– 8. 63. Gaasch WH. Left ventricular radius to wall thickness ratio. Am J Cardiol 1979; 43:1189 –94. 64. Spann JF, Bove AA, Natarajan G, Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 1980; 62:576–82. 65. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur Heart J 1988; 9 Suppl E: 19–23. 66. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976; 18:255– 64. 67. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59:679–88. 68. Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis. Circulation 1981; 64:126–34. 69. Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 1980; 62:42– 8. 70. Gaasch WH, Levine HJ, Quinones MA, Alexander JK. Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol 1976; 38:645–53. 71. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984; 69:55–65. 72. Murakami T, Hess OM, Gage JE, Grimm J, Krayenbuehl HP.Diastolic filling dynamics in patients with aortic stenosis. Circulation1986; 73:1162–74. 73. Gaasch WH. Diagnosis and treatment of heart failure based on leftventricular systolic or diastolic dysfunction. JAMA 1994; 271:1276–80. 74. Stott DK, Marpole DG, Bristow JD, Kloster FE, Griswold HE.The role of left atrial transport in aortic and mitral stenosis.Circulation 1970;41:1031– 41. 75. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW.Regional myocardial blood flow during exercise in dogs with chronicleft ventricular hypertrophy. Circ Res 1981; 48:76–87. 76. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL.Decreased coronary reserve: a mechanism for angina pectoris inpatients with aortic stenosis and normal coronary arteries. N EnglJ Med 1982; 307:1362– 6. 77. Carabello BA. Clinical practice: aortic stenosis. N Engl J Med2002; 346:677– 82. 78. Koyanagi S, Eastham C, Marcus ML. Effects of chronic hypertensionand left ventricular hypertrophy on the incidence of suddencardiac death after coronary artery occlusion in conscious dogs.Circulation 1982; 65:1192–7. 79. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increasedsize of myocardial infarction in dogs with chronic hypertension andleft ventricular hypertrophy. Circ Res 1982; 50:55– 62. 80. Gaasch WH, Zile MR, Hoshino PK, Weinberg EO, Rhodes DR,Apstein CS. Tolerance of the hypertrophic heart to ischemia:studies in compensated and failing dog hearts with pressure overloadhypertrophy. Circulation 1990; 81:1644 –53. 81. Aurigemma G, Battista S, Orsinelli D, Sweeney A, Pape L,Cuenoud H. Abnormal left ventricular intracavitary flow accelerationin patients undergoing aortic valve replacement for aorticstenosis: a marker for high postoperative morbidity and mortality.Circulation 1992;86:926 –36. 82. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differencesin left ventricular function in aortic stenosis of the elderly. Circulation1992; 86:1099 –107. 83. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH.Left ventricular hypertrophy and mortality after aortic valve replacementfor aortic stenosis: a high risk subgroup identified by preoperativerelative wall thickness. J Am Coll Cardiol 1993; 22:1679–83. 84. Aurigemma GP, Silver KH, McLaughlin M, Mauser J, GaaschWH. Impact of chamber geometry and gender on left ventricularsystolic function in patients _60 years of age with aortic stenosis.Am J Cardiol 1994; 74:794–8. 85. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progressionof valvular aortic stenosis in adults: literature review and clinicalimplications. Am Heart J 1996; 132:408 –17. 86. Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA,Bode RS Jr. Rate of progression of severity of valvular aortic stenosisin the adult. Am Heart J 1979; 98:689 –700. 87. Wagner S, Selzer A. Patterns of progression of aortic stenosis: alongitudinal hemodynamic study. Circulation 1982; 65:709 –12. 88. Jonasson R, Jonsson B, Nordlander R, Orinius E, Szamosi A. Rateof progression of severity of valvular aortic stenosis. Acta Med Scand1983; 213:51– 4. 89. Nestico PF, DePace NL, Kimbiris D, et al. Progression of isolatedaortic stenosis: analysis of 29 patients having more than 1 cardiaccatheterization. Am J Cardiol 1983; 52:1054–8. 90. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progressionof aortic stenosis in adults assessed by Doppler echocardiography.J Am Coll Cardiol 1989;13:545–50. 91. Roger VL, Tajik AJ, Bailey KR, Oh JK, Taylor CL, Seward JB.Progression of aortic stenosis in adults: new appraisal using Dopplerechocardiography. Am Heart J 1990; 119:331– 8. 92. Davies SW, Gershlick AH, Balcon R. Progression of valvar aorticstenosis: a long-term retrospective study. Eur Heart J 1991; 12:10–4. 93. Faggiano P, Ghizzoni G, Sorgato A, et al. Rate of progression ofvalvular aortic stenosis in adults. Am J Cardiol 1992; 70:229 –33. 94. Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D.Progression of aortic stenosis: role of age and concomitant coronaryartery disease. Chest 1993; 103:1715–9. 95. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aorticstenosis in 394 patients: relation to changes in myocardial and mitralvalve dysfunction. J Am Coll Cardiol 1995; 25:305–10. 96. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome insevere, asymptomatic aortic stenosis. N Engl J Med 2000; 343:611–7. 97. Vaturi M, Porter A, Adler Y, et al. The natural history of aorticvalve disease after mitral valve surgery. J Am Coll Cardiol 1999; 33:2003–8. 297 98. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aorticstenosis. Natural history and risk stratification by echocardiography.Eur Heart J 2004; 25:199 –205. 99. Cosmi JE, Kort S, Tunick PA, et al. The risk of the development ofaortic stenosis in patients with “benign” aortic valve thickening.Arch Intern Med 2002; 162:2345–7. 100. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associatedwith calcific aortic valve disease: Cardiovascular Health Study. J AmColl Cardiol 1997; 29:630–4. 101. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS.Association of aortic-valve sclerosis with cardiovascular mortalityand morbidity in the elderly. N Engl J Med 1999; 341:142–7. 102. Olsen MH, Wachtell K, Bella JN, et al. Aortic valve sclerosis relatesto cardiovascular events in patients with hypertension (a LIFEsubstudy). Am J Cardiol 2005;95:132– 6. 103. Taylor HA Jr, Clark BL, Garrison RJ, et al. Relation of aortic valvesclerosis to risk of coronary heart disease in African-Americans.Am J Cardiol 2005;95:401– 4. 104. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired vonWillebrand syndrome in aortic stenosis. N Engl J Med 2003; 349:343–9. 105. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38:61–7. 106. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valvereplacement on survival. Circulation 1982; 66:1105–10. 107. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous courseof aortic valve disease. Eur Heart J 1987; 8:471– 83. 108. Horstkotte D, Loogen F. The natural history of aortic valvestenosis. Eur Heart J 1988;9 Suppl E:57–64. 109. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML,Gibson RS. Comparison of outcome of asymptomatic to symptomaticpatients older than 20 years of age with valvular aortic stenosis.Am J Cardiol 1988; 61:123–30. 110. Sprigings DC, Forfar JC. How should we manage symptomaticaortic stenosis in the patient who is 80 or older? Br Heart J1995; 74:481– 4. 111. Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M.Natural history of aortic valve stenosis of varying severity in theelderly. Am J Cardiol 1996; 78:97– 01. 112. Frank S, Johnson A, Ross J Jr. Natural history of valvular aorticstenosis. Br Heart J 1973; 35:41– 6. 113. Chizner MA, Pearle DL, deLeon AC Jr. The natural history ofaortic stenosis in adults. Am Heart J 1980; 99:419 –24. 114. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The naturalhistory of adults with asymptomatic, hemodynamically significantaortic stenosis. J Am Coll Cardiol 1990; 15:1012–7. 115. Kennedy KD, Nishimura RA, Holmes DR Jr, Bailey KR. Naturalhistory of moderate aortic stenosis. J Am Coll Cardiol 1991; 17:313–9. 116. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622adults with asymptomatic, hemodynamically significant aortic stenosisduring prolonged follow-up. Circulation 2005; 111:3290 –5. 117. Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatmentdecision in asymptomatic aortic valve stenosis: role of exercisetesting. Heart 2001; 86:381– 6. 118. Das P, Rimington H, Chambers J. Exercise testing to stratify risk inaortic stenosis. Eur Heart J 2005; 26:1309 –13. 298 119. Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M,Otto CM. Physical examination in valvular aortic stenosis: correlationwith stenosis severity and prediction of clinical outcome. AmHeart J 1999; 137:298 –306. 120. Nylander E, Ekman I, Marklund T, Sinnerstad B, Karlsson E,Wranne B. Severe aortic stenosis in elderly patients. Br Heart J1986; 55:480 –7. 121. Atwood JE, Kawanishi S, Myers J, Froelicher VF. Exercise testingin patients with aortic stenosis. Chest 1988; 93:1083–7. 122. Clyne CA, Arrighi JA, Maron BJ, Dilsizian V, Bonow RO, CannonRO III. Systemic and left ventricular responses to exercise stress inasymptomatic patients with valvular aortic stenosis. Am J Cardiol1991; 68:1469 –76. 123. Otto CM, Pearlman AS, Kraft CD, Miyake-Hull CY, Burwash IG,Gardner CJ. Physiologic changes with maximal exercise in asymptomaticvalvular aortic stenosis assessed by Doppler echocardiography.J Am Coll Cardiol 1992; 20:1160 –7. 124. Alborino D, Hoffmann JL, Fournet PC, Bloch A. Value of exercisetesting to evaluate the indication for surgery in asymptomaticpatients with valvular aortic stenosis. J Heart Valve Dis 2002; 11:204–9. 125. Takeda S, Rimington H, Chambers J. Prediction of symptom-onsetin aortic stenosis: a comparison of pressure drop/flow slope andhaemodynamic measures at rest. Int J Cardiol 2001; 81:131–7. 126. Wilmshurst PT, Stevenson RN, Griffiths H, Lord JR. A casecontrolinvestigation of the relation between hyperlipidaemia andcalcific aortic valve stenosis. Heart 1997; 78:475–9. 127. Palta S, Pai AM, Gill KS, Pai RG. New insights into theprogression of aortic stenosis: implications for secondary prevention.Circulation 2000; 101:2497–502. 128. Ngo MV, Gottdiener JS, Fletcher RD, Fernicola DJ, Gersh BJ.Smoking and obesity are associated with the progression of aorticstenosis. Am J Geriatr Cardiol 2001; 10:86 –90. 129. Chandra HR, Goldstein JA, Choudhary N, et al. Adverse outcomein aortic sclerosis is associated with coronary artery disease andinflammation. J Am Coll Cardiol 2004; 43:169 –75. 130. Rajamannan NM, Otto CM. Targeted therapy to prevent progressionof calcific aortic stenosis. Circulation 2004; 110:1180 –2. 131. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association ofcoronary risk factors and use of statins with progression of mildvalvular aortic stenosis in older persons. Am J Cardiol 2001; 88:693–5. 132. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL,Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductaseinhibitors on the progression of calcific aortic stenosis. Circulation2001; 104:2205–9. 133. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O’Brien KD.HMG CoA reductase inhibitor (statin) and aortic valve calcium.Lancet 2002;359:1125– 6. 134. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valvecalcification: association with coronary atherosclerosis and cardiovascularrisk factors. Circulation 2001; 104:1927–32. 135. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-SaranoM. Association of cholesterol levels, hydroxymethylglutarylcoenzyme-A reductase inhibitor treatment, and progression ofaortic stenosis in the community. J Am Coll Cardiol 2002; 40:1723–30. 136. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensinconvertingenzyme inhibitors delay progression of aortic stenosis.Circulation 2004; 110:1291–5. 299 137. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial ofintensive lipid-lowering therapy in calcific aortic stenosis. N EnglJ Med 2005; 352:2389 – 97. 138. Bonow RO, Cheitlin M, Crawford M, Douglas PS. 36th BethesdaConference: recommendations for determining eligibility for competitionin athletes with cardiovascular abnormalties. Task Force 3:Valvular Heart Disease. J Am Coll Cardiol 2005; 14:1334–40. 139. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the areaof the stenotic mitral valve, other cardiac valves, and centralcirculatory shunts. Am Heart J 1951; 41:1–29. 140. Burwash IG, Hay KM, Chan KL. Hemodynamic stability of valvearea, valve resistance, and stroke work loss in aortic stenosis: acomparative analysis. J Am Soc Echocardiogr 2002; 15:814 –22. 141. Bache RJ, Wang Y, Jorgensen CR. Hemodynamic effects of exercisein isolated valvular aortic stenosis. Circulation 1971; 44:1003–13. 142. deFilippi CR, Willett DL, Brickner ME, et al. Usefulness ofdobutamine echocardiography in distinguishing severe from nonseverevalvular aortic stenosis in patients with depressed left ventricularfunction and low transvalvular gradients. Am J Cardiol 1995; 75:191– 4. 143. Bermejo J, Garcia-Fernandez MA, Torrecilla EG, et al. Effects ofdobutamine on Doppler echocardiographic indexes of aortic stenosis.J Am Coll Cardiol 1996; 28:1206 –13. 144. Lin SS, Roger VL, Pascoe R, Seward JB, Pellikka PA. Dobutaminestress Doppler hemodynamics in patients with aortic stenosis:feasibility, safety, and surgical correlations. Am Heart J 1998; 136:1010–6. 145. Monin JL, Monchi M, Gest V, Duval-Moulin AM, Dubois-RandeJL, Gueret P. Aortic stenosis with severe left ventricular dysfunctionand low transvalvular pressure gradients: risk stratification by lowdosedobutamine echocardiography. J Am Coll Cardiol 2001; 37:2101–7. 146. Schwammenthal E, Vered Z, Moshkowitz Y, et al. Dobutamineechocardiography in patients with aortic stenosis and left ventriculardysfunction: predicting outcome as a function of managementstrategy. Chest 2001; 119:1766 –77. 147. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, HiganoST, Holmes DR Jr. Low-output, low-gradient aortic stenosis inpatients with depressed left ventricular systolic function: the clinicalutility of the dobutamine challenge in the catheterization laboratory.Circulation 2002; 106:809 –13. 148. Monin JL, Quere JP, Monchi M, et al. Low-gradient aorticstenosis: operative risk stratification and predictors for long-termoutcome: a multicenter study using dobutamine stress hemodynamics.Circulation 2003; 108:319 –24. 149. Otto CM. Valvular aortic stenosis: disease severity and timing ofintervention. J Am Coll Cardiol 2006; 47:2141–51. 150. Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosiswith impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978; 58:255– 64. 151. Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aorticstenosis in patients 60 years of age or older: left ventricular functionand 10-year survival after valve replacement. Circulation 1981; 64:II184 –II188. 152. Lund O. Preoperative risk evaluation and stratification of long-termsurvival after valve replacement for aortic stenosis: reasons for earlieroperative intervention. Circulation 1990; 82:124 –39. 300 301 153. Kouchoukos NT, Davila-Roman VG, Spray TL, Murphy SF,Perrillo JB. Replacement of the aortic root with a pulmonaryautograft in children and young adults with aortic-valve disease.N Engl J Med 1994; 330:1– 6. 154. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacementfor aortic stenosis with severe left ventricular dysfunction: prognosticindicators. Circulation 1997; 95:2395– 400. 155. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relativesurvival after aortic valve replacement. J Am Coll Cardiol 2000; 35:747–56. 156. Brogan WC III, Grayburn PA, Lange RA, Hillis LD. Prognosisafter valve replacement in patients with severe aortic stenosis and alow transvalvular pressure gradient. J Am Coll Cardiol 1993; 21:1657–60. 157. Connolly HM, Oh JK, Schaff HV, et al. Severe aortic stenosis withlow transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation 2000; 101:1940–6. 158. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valvereplacement for severe aortic stenosis with low transvalvular gradientsand severe left ventricular dysfunction. J Am Coll Cardiol2002; 39:1356–63. 159. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S,Salamon R. European system for cardiac operative risk evaluation(EuroSCORE). Eur J Cardiothorac Surg 1999;16:9 –13. 160. Nashef SA, Roques F, Hammill BG, et al. Validation of EuropeanSystem for Cardiac Operative Risk Evaluation (EuroSCORE) inNorth American cardiac surgery. Eur J Cardiothorac Surg 2002; 22:101–5. 161. Shroyer AL, Coombs LP, Peterson ED, et al. The Society ofThoracic Surgeons: 30-day operative mortality and morbidity riskmodels. Ann Thorac Surg 2003; 75:1856–64. 162. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, TaylorKM. Generic, simple risk stratification model for heart valvesurgery. Circulation 2005; 112:224 –31. 163. Carabello BA. Timing of valve replacement in aortic stenosis:moving closer to perfection. Circulation 1997; 95: 2241–3. 164. Edwards FH, Peterson ED, Coombs LP, et al. Prediction ofoperative mortality after valve replacement surgery. J Am CollCardiol 2001; 37:885–92. 165. Society of Thoracic Surgeons National Cardiac Surgery Database. Available at:http://www.sts.org/documents/pdf/STSExecutiveSummary Fall2005.pdf. Acessed November 2005. 166. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volumeand surgical mortality in the United States. N Engl J Med2002; 346:1128 –37. 167. Goodney PP, O’Connor GT, Wennberg DE, Birkmeyer JD. Dohospitals with low mortality rates in coronary artery bypass alsoperform well in valve replacement? Ann Thorac Surg 2003; 76:1131–6. 168. Banbury MK, Cosgrove DM III, White JA, Blackstone EH, FraterRW, Okies JE. Age and valve size effect on the long-term durabilityof the CarpentierEdwards aortic pericardial bioprosthesis. AnnThorac Surg 2001; 72:753–7. 169. Byrne JG, Karavas AN, Mihaljevic T, Rawn JD, Aranki SF, CohnLH. Role of the cryopreserved homograft in isolated elective aorticvalve replacement. Am J Cardiol 2003; 91:616 –9. 170. Yacoub M, Rasmi NR, Sundt TM, et al. Fourteen-year experiencewith homovital homografts for aortic valve replacement. J ThoracCardiovasc Surg 1995; 110:186 –93. 302 171. O’Brien MF, Stafford EG, Gardner MA, et al. Allograft aortic valvereplacement: long-term follow-up. Ann Thorac Surg 1995; 60:S65–S70. 172. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves.N Engl J Med 1996; 335:407–16. 173. Banbury MK, Cosgrove DM III, Lytle BW, Smedira NG, Sabik JF,Saunders CR. Long-term results of the Carpentier-Edwards pericardialaortic valve: a 12-year follow-up. Ann Thorac Surg 1998; 66:S73–S76. 174. Hammermeister K, Sethi GK, Henderson WG, Grover FL, OprianC, Rahimtoola SH. Outcomes 15 years after valve replacement witha mechanical versus a bioprosthetic valve: final report of theVeterans Affairs randomized trial. J Am Coll Cardiol 2000; 36:1152–8. 175. Akins CW. Mechanical cardiac valvular prostheses. Ann ThoracSurg 1991; 52:161–72. 176. Kvidal P, Bergstrom R, Malm T, Stahle E. Long-term follow-up ofmorbidity and mortality after aortic valve replacement with amechanical valve prosthesis. Eur Heart J 2000; 21:1099 –111. 177. Emery RW, Erickson CA, Arom KV, et al. Replacement of theaortic valve in patients under 50 years of age: long-term follow-up ofthe St. Jude Medical prosthesis. Ann Thorac Surg 2003; 75:1815–9. 178. Murday AJ, Hochstitzky A, Mansfield J, et al. A prospectivecontrolled trial of St. Jude versus Starr Edwards aortic and mitralvalve prostheses. Ann Thorac Surg 2003; 76:66 –73. 179. Lund O, Larsen KE. Cardiac pathology after isolated valve replacementfor aortic stenosis in relation to preoperative patient status:early and late autopsy findings. Scand J Thorac Cardiovasc Surg1989; 23:263–70. 180. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptidespredict symptom-free survival and postoperative outcome in severeaortic stenosis. Circulation 2004; 109:2302– 8. 181. Moreira FC, Manfroi WC, Werutsky G, Bittencourt JA. Managementof mild aortic stenosis in patients undergoing coronary bypasssurgery. Arq Bras Cardiol 2001; 77:494 –9. 182. Filsoufi F, Aklog L, Adams DH, Byrne JG. Management of mild tomoderate aortic stenosis at the time of coronary artery bypassgrafting. J Heart Valve Dis 2002; 11 Suppl 1:S45–S49. 183. Smith WT, Ferguson TB Jr, Ryan T, Landolfo CK, Peterson ED.Should coronary artery bypass graft surgery patients with mild ormoderate aortic stenosis undergo concomitant aortic valve replacement?A decision analysis approach to the surgical dilemma. J AmColl Cardiol 2004; 44:1241–7. 184. Pereira JJ, Balaban K, Lauer MS, Lytle B, Thomas JD, Garcia MJ.Aortic valve replacement in patients with mild or moderate aorticstenosis and coronary bypass surgery. Am J Med 2005; 118:735– 42. 185. Gillinov AM, Garcia MJ. When is concomitant aortic valvereplacement indicated in patients with mild to moderate stenosisundergoing coronary revascularization? Curr Cardiol Rep 2005; 7:101–4. 186. Eslami M, Rahimtoola SH. Prophylactic aortic valve replacement inolder patients for mild aortic stenosis during coronary bypasssurgery. Am J Geriatr Cardiol 2003; 12:197–200. 187. Karagounis A, Valencia O, Chandrasekaran V, Smith J, Brecker S,Jahangiri M. Management of patients undergoing coronary arterybypass graft surgery with mild to moderate aortic stenosis. J HeartValve Dis 2004; 13:369 –73. 303 188. Lababidi Z, Wu JR, Walls JT. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am J Cardiol 1984; 53:194 –7. 189. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B.Percutaneous transluminal valvuloplasty of acquired aortic stenosisin elderly patients: an alternative to valve replacement? Lancet1986; 1:63–7. 190. Safian RD, Berman AD, Diver DJ, et al. Balloon aortic valvuloplastyin 170 consecutive patients. N Engl J Med 1988; 319:125–30. 191. McKay RG, Safian RD, Lock JE, et al. Balloon dilatation of calcificaortic stenosis in elderly patients: postmortem, intraoperative, andpercutaneous valvuloplasty studies. Circulation 1986; 74:119 –25. 192. Safian RD, Mandell VS, Thurer RE, et al. Postmortem andintraoperative balloon valvuloplasty of calcific aortic stenosis inelderly patients: mechanisms of successful dilation. J Am CollCardiol 1987; 9:655– 60. 193. Isner JM, Samuels DA, Slovenkai GA, et al. Mechanism of aorticballoon valvuloplasty: fracture of valvular calcific deposits. AnnIntern Med 1988; 108:377– 80. 194. Letac B, Cribier A, Koning R, Bellefleur JP. Results of percutaneoustransluminal valvuloplasty in 218 adults with valvular aortic stenosis.Am J Cardiol 1988; 62:598–605. 195. Block PC, Palacios IF. Clinical and hemodynamic follow-up afterpercutaneous aortic valvuloplasty in the elderly. Am J Cardiol1988; 62:760 –3. 196. Sherman W, Hershman R, Lazzam C, Cohen M, Ambrose J,Gorlin R. Balloon valvuloplasty in adult aortic stenosis: determinantsof clinical outcome. Ann Intern Med 1989; 110:421–5. 197. Brady ST, Davis CA, Kussmaul WG, Laskey WK, Hirshfeld JW Jr,Herrmann HC. Percutaneous aortic balloon valvuloplasty in octogenarians:morbidity and mortality. Ann Intern Med 1989; 110:761–6. 198. Hayes SN, Holmes DR Jr, Nishimura RA, Reeder GS. Palliativepercutaneous aortic balloon valvuloplasty before noncardiac operationsand invasive diagnostic procedures. Mayo Clin Proc 1989; 64:753–7. 199. Fields CD, Rosenfield K, Lasordo DW, Isner JM. Percutaneousballoon valvuloplasty: current status. Curr Opinion Cardiol 1989; 4:229–42. 200. Ferguson JJ III, Riuli EP, Massumi A, et al. Balloon aorticvalvuloplasty: the Texas Heart Institute experience. Tex Heart InstJ 1990; 17:23–30. 201. Berland J, Cribier A, Savin T, Lefebvre E, Koning R, Letac B.Percutaneous balloon valvuloplasty in patients with severe aorticstenosis and low ejection fraction: immediate results and 1–yearfollow-up. Circulation 1989; 79: 1189 –96. 202. Davidson CJ, Harrison JK, Leithe ME, Kisslo KB, Bashore TM.Failure of balloon aortic valvuloplasty to result in sustained clinicalimprovement in patients with depressed left ventricular function.Am J Cardiol 1990;65:72–7. 203. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcomeafter balloon aortic valvuloplasty: insights into prognosis of valvularaortic stenosis. Circulation 1994; 89:642–50. 204. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aorticvalvuloplasty in adults: failure of procedure to improve long-termsurvival. J Am Coll Cardiol 1995; 26:1522– 8. 205. Block PC. Aortic valvuloplasty—a valid alternative? N Engl J Med1988; 319:169 –71. 304 206. Nishimura RA, Holmes DR Jr, Reeder GS. Percutaneous balloonvalvuloplasty. Mayo Clin Proc 1990; 65:198 –220. 207. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcificaortic stenosis: a limited role. J Am Coll Cardiol 1994; 23:1076–8. 208. O’Keefe JH Jr, Shub C, Rettke SR. Risk of noncardiac surgicalprocedures in patients with aortic stenosis. Mayo Clin Proc 1989; 64:400 –5. 209. Torsher LC, Shub C, Rettke SR, Brown DL. Risk of patients withsevere aortic stenosis undergoing noncardiac surgery. Am J Cardiol1998; 81:448 –52. 210. Raymer K, Yang H. Patients with aortic stenosis: cardiac complicationsin non-cardiac surgery. Can J Anaesth 1998; 45:855–9. 211. Brighouse D. Anaesthesia for caesarean section in patients with aortic stenosis: the case for regional anaesthesia. Anaesthesia 1998; 53:107–9. 212. Christ M, Sharkova Y, Geldner G, Maisch B. Preoperative andperioperative care for patients with suspected or established aorticstenosis facing noncardiac surgery. Chest 2005; 128:2944 –53. 213. Khot UN, Novaro GM, Popovic ZB, et al. Nitroprusside incritically ill patients with left ventricular dysfunction and aorticstenosis. N Engl J Med 2003; 348:1756–63. 214. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-yearcomparison of a Bjork-Shiley mechanical heart valve with porcinebioprostheses. N Engl J Med 1991; 324:573–9. 215. Tsai TP, Denton TA, Chaux A, et al. Results of coronary arterybypass grafting and/or aortic or mitral valve operation in patients or 90 years of age. Am J Cardiol 1994; 74:960–2. 216. Logeais Y, Langanay T, Roussin R, et al. Surgery for aortic stenosisin elderly patients: a study of surgical risk and predictive factors.Circulation 1994; 90:2891– 8. 217. Bouma BJ, van den Brink RB, van der Meulen JH, et al. To operateor not on elderly patients with aortic stenosis: the decision and itsconsequences. Heart 1999; 82:143– 8. 218. Abdul-Hamid AR, Mulley GP. Why do so few older people withaortic stenosis have valve replacement surgery? Age Ageing 1999; 28:261– 4. 219. Iung B, Cachier A, Baron G, et al. Decision-making in elderlypatients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26:2714 –20. 220. Cigarroa JE, Isselbacher EM, DeSanctis RW, Eagle KA. Diagnosticimaging in the evaluation of suspected aortic dissection: oldstandards and new directions. N Engl J Med 1993; 328:35– 43. 221. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis ofthoracic aortic dissection by noninvasive imaging procedures.N Engl J Med 1993; 328:1–9. 222. Smith MD, Cassidy JM, Souther S, et al. Transesophageal echocardiographyin the diagnosis of traumatic rupture of the aorta.N Engl J Med 1995;332:356–62. 223. Rahimtoola SH. Recognition and management of acute aorticregurgitation. Heart Dis Stroke 1993; 2:217–21. 224. Kern MJ, Serota H, Callicoat P, et al. Use of coronary arteriographyin the preoperative management of patients undergoing urgentrepair of the thoracic aorta. Am Heart J 1990; 119:143– 8. 225. Israel DH, Sharma SK, Ambrose JA, Ergin MA, Griepp RR.Cardiac catheterization and selective coronary angiography in ascendingaortic aneurysm or dissection. Cathet Cardiovasc Diagn1994; 32:232–7. 226. Rizzo RJ, Aranki SF, Aklog L, et al. Rapid noninvasive diagnosisand surgical repair of acute ascending aortic dissection: improvedsurvival with less angiography. J Thorac Cardiovasc Surg 1994; 108:567–74. 227. Penn MS, Smedira N, Lytle B, Brener SJ. Does coronary angiographybefore emergency aortic surgery affect in-hospital mortality? J Am Coll Cardiol 2000; 35:889 –94. 228. Grossman W, Jones D, McLaurin LP. Wall stress and patterns ofhypertrophy in the human left ventricle. J Clin Invest 1975; 56:56–64. 229. Ross J Jr, McCullagh WH. Nature of enhanced performance of thedilated left ventricle in the dog during chronic volume overloading.Circ Res 1972; 30:549–6. 230. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardialperformance and load between patients with similar amounts ofchronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol1984; 3:916 –23. 231. Carabello BA. Aortic regurgitation: a lesion with similarities to bothaortic stenosis and mitral regurgitation. Circulation 1990; 82:1051–3. 232. Ricci DR. Afterload mismatch and preload reserve in chronic aorticregurgitation. Circulation 1982; 66:826 –34. 233. Ross J Jr. Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. J Am Coll Cardiol 1985; 5:811–26. 234. Nitenberg A, Foult JM, Antony I, Blanchet F, Rahali M. Coronaryflow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries. J Am CollCardiol 1988; 11:478–86. 235. Gaasch WH, Andrias CW, Levine HJ. Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function. Circulation 1978; 58:825–36. 236. Schwarz F. Flameng W. Langebartels F. Sesto M. Walter P. Schlepper M. Impaired left ventricular function in chronic aorticvalve disease: survival and function after replacement by Bjork-Shiley prosthesis. Circulation 1979; 60:48 –58. 237. Borer JS, Rosing DR, Kent KM, et al. Left ventricular function atrest and during exercise after aortic valve replacement in patientswith aortic regurgitation. Am J Cardiol 1979; 44:1297–305. 238. Clark DG, McAnulty JH, Rahimtoola SH. Valve replacement inaortic insufficiency with left ventricular dysfunction. Circulation1980; 61:411–21. 239. Toussaint C, Cribier A, Cazor JL, Soyer R, Letac B. Hemodynamicand angiographic evaluation of aortic regurgitation 8 and 27 monthsafter aortic valve replacement. Circulation 1981; 64:456–63. 240. Carroll JD, Gaasch WH, Zile MR, Levine HJ. Serial changes in leftventricular function after correction of chronic aortic regurgitation: dependence on early changes in preload and subsequent regressionof hypertrophy. Am J Cardiol 1983; 51:476–82. 241. Bonow RO, Rosing DR, Maron BJ, et al. Reversal of left ventriculardysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction.Circulation 1984; 70:570 –9. 242. Fioretti P, Roelandt J, Sclavo M, et al. Postoperative regression ofleft ventricular dimensions in aortic insufficiency: a long-termechocardiographic study. J Am Coll Cardiol 1985; 5:856–61. 305 306 243. Carabello BA, Usher BW, Hendrix GH, Assey ME, Crawford FA, Leman RB. Predictors of outcome for aortic valve replacement inpatients with aortic regurgitation and left ventricular dysfunction: achange in the measuring stick. J Am Coll Cardiol 1987; 10:991–7. 244. Taniguchi K, Nakano S, Hirose H, et al. Preoperative left ventricularfunction: minimal requirement for successful late results of valvereplacement for aortic regurgitation. J Am Coll Cardiol 1987; 10:510–8. 245. Bonow RO, Dodd JT, Maron BJ, et al. Long-term serial changes inleft ventricular function and reversal of ventricular dilatation aftervalve replacement for chronic aortic regurgitation. Circulation1988; 78:1108 –20. 246. Borer JS, Herrold EM, Hochreiter C, et al. Natural history of leftventricular performance at rest and during exercise after aortic valvereplacement for aortic regurgitation. Circulation 1991; 84:III133–9. 247. Cohn PF, Gorlin R, Cohn LH, Collins JJ Jr. Left ventricularejection fraction as a prognostic guide in surgical treatment ofcoronary and valvular heart disease. Am J Cardiol 1974; 34:136 –1. 248. Copeland JG, Griepp RB, Stinson EB, Shumway NE. Long-termfollow-up after isolated aortic valve replacement. J Thorac CardiovascSurg 1977; 74:875– 89. 249. Herreman F, Ameur A, de Vernejoul F, et al. Pre- and postoperativehemodynamic and cineangiocardiographic assessment of left ventricularfunction in patients with aortic regurgitation. Am Heart J1979; 98:63–72. 250. Cunha CL, Giuliani ER, Fuster V, Seward JB, Brandenburg RO, McGoon DC. Preoperative M-mode echocardiography as a predictorof surgical results in chronic aortic insufficiency. J ThoracCardiovasc Surg 1980; 79:256 –5. 251. Forman R, Firth BG, Barnard MS. Prognostic significance ofpreoperative left ventricular ejection fraction and valve lesion inpatients with aortic valve replacement. Am J Cardiol 1980; 45:1120–5. 252. Greves J, Rahimtoola SH, McAnulty JH, et al. Preoperative criteriapredictive of late survival following valve replacement for severeaortic regurgitation. Am Heart J 1981; 101:300–8. 253. Gaasch WH, Carroll JD, Levine HJ, Criscitiello MG. Chronicaortic regurgitation: prognostic value of left ventricular end-systolicdimension and enddiastolic radius/thickness ratio. J Am CollCardiol 1983; 1:775– 82. 254. Bonow RO, Picone AL, McIntosh CL, et al. Survival and functionalresults after valve replacement for aortic regurgitation from1976 to 1983: impact of preoperative left ventricular function.Circulation 1985; 72:1244 –56. 255. Carabello BA, Williams H, Gash AK, et al. Hemodynamic predictorsof outcome in patients undergoing valve replacement. Circulation1986; 74:1309 –16. 256. Michel PL, Iung B, Abou JS, et al. The effect of left ventricularsystolic function on long term survival in mitral and aortic regurgitation.J Heart Valve Dis 1995; 4 Suppl 2:S160–8. 257. Henry WL, Bonow RO, Borer JS, et al. Observations on theoptimum time for operative intervention for aortic regurgitation, I:evaluation of the results of aortic valve replacement in symptomaticpatients. Circulation 1980; 61:471– 83. 258. Kumpuris AG, Quinones MA, Waggoner AD, Kanon DJ, NelsonJG, Miller RR. Importance of preoperative hypertrophy, wall stressand end-systolic dimension as echocardiographic predictors ofnormalization of left ventricular dilatation after valve replacement inchronic aortic insufficiency. Am J Cardiol 1982; 49:1091–100. 259. Fioretti P, Roelandt J, Bos RJ, et al. Echocardiography in chronicaortic insufficiency: is valve replacement too late when left ventricularend-systolic dimension reaches 55 mm? Circulation 1983; 67:216–21. 260. Stone PH, Clark RD, Goldschlager N, Selzer A, Cohn K. Determinantsof prognosis of patients with aortic regurgitation whoundergo aortic valve replacement. J Am Coll Cardiol 1984; 3:1118–26. 261. Daniel WG, Hood WP Jr, Siart A, et al. Chronic aortic regurgitation:reassessment of the prognostic value of preoperative leftventricular end-systolic dimension and fractional shortening. Circulation1985; 71:669–80. 262. Cormier B, Vahanian A, Luxereau P, Kassab R, Acar J. Shouldasymptomatic or mildly symptomatic aortic regurgitation be operated on? Z Kardiol 1986; 75 Suppl 2:141–5. 263. Sheiban I, Trevi GP, Casarotto D, et al. Aortic valve replacement inpatients with aortic incompetence: preoperative parameters influencinglong-term results. Z Kardiol 1986;75 Suppl 2:146 –54. 264. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR,Seward JB. Aortic regurgitation complicated by extreme left ventriculardilation: longterm outcome after surgical correction. J AmColl Cardiol 1996; 27:670 –7. 265. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR,Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol1997; 30:746 –52. 266. Turina J, Milincic J, Seifert B, Turina M. Valve replacement inchronic aortic regurgitation: true predictors of survival after extendedfollow-up. Circulation 1998; 98:II100–6. 267. Tornos P, Sambola A, Permanyer-Miralda G, Evangelista A, Gomez Z, SolerSoler J. Long-term outcome of surgically treatedaortic regurgitation: influence of guideline adherence toward earlysurgery. J Am Coll Cardiol 2006; 47:1012–7. 268. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history ofasymptomatic patients with aortic regurgitation and normal leftventricular function. Circulation 1983; 68:509 –17. 269. Scognamiglio R, Fasoli G, Dalla VS. Progression of myocardialdysfunction in asymptomatic patients with severe aortic insuffi-ciency. Clin Cardiol 1986; 9:151– 6. 270. Siemienczuk D, Greenberg B, Morris C, et al. Chronic aorticinsufficiency: factors associated with progression to aortic valvereplacement. Ann Intern Med 1989; 110:587–92. 271. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-termassessment of the natural history of asymptomatic patients withchronic aortic regurgitation and normal left ventricular systolicfunction. Circulation 1991; 84:1625–35. 272. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla VS.Nifedipine in asymptomatic patients with severe aortic regurgitationand normal left ventricular function. N Engl J Med 1994; 331:689–94. 273. Tornos MP, Olona M, Permanyer-Miralda G, et al. Clinicaloutcome of severe asymptomatic chronic aortic regurgitation: along-term prospective followup study. Am Heart J 1995; 130:333–9. 274. Ishii K, Hirota Y, Suwa M, Kita Y, Onaka H, Kawamura K. Naturalhistory and left ventricular response in chronic aortic regurgitation.Am J Cardiol 1996;78:357– 61. 275. Borer JS, Hochreiter C, Herrold EM, et al. Prediction of indicationsfor valve replacement among asymptomatic or minimallysymptomatic patients with 307 chronic aortic regurgitation and normalleft ventricular performance. Circulation 1998; 97:525–34. 276. Tarasoutchi F, Grinberg M, Spina GS, et al. Ten-year clinicallaboratory follow-up after application of a symptom-based therapeuticstrategy to patients with severe chronic aortic regurgitation ofpredominant rheumatic etiology. J Am Coll Cardiol 2003; 41:1316–24. 277. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G,Soler-Soler J. Long-term vasodilator therapy in patients with severeaortic regurgitation. N Engl J Med 2005; 353:1342–9. 278. Greenberg B, Massie B, Bristow JD, et al. Long-term vasodilatortherapy of chronic aortic insufficiency: a randomized doubleblinded,placebo-controlled clinical trial. Circulation 1988; 78:92–103. 279. Shen WF, Roubin GS, Choong CY, et al. Evaluation of relationshipbetween myocardial contractile state and left ventricular functionin patients with aortic regurgitation. Circulation 1985; 71:31– 8. 280. Kawanishi DT, McKay CR, Chandraratna PA, et al. Cardiovascularresponse to dynamic exercise in patients with chronic symptomaticmild-to-moderate and severe aortic regurgitation. Circulation 1986; 73:62–72. 281. Henry WL, Bonow RO, Rosing DR, Epstein SE. Observations onthe optimum time for operative intervention for aortic regurgitation,II: serial echocardiographic evaluation of asymptomatic patients.Circulation 1980;61:484 –92. 282. McDonald IG, Jelinek VM. Serial M-mode echocardiography insevere chronic aortic regurgitation. Circulation 1980; 62:1291– 6. 283. Bonow RO. Radionuclide angiography in the management ofasymptomatic aortic regurgitation. Circulation 1991; 84:I296 –302. 284. Hegglin R, Scheu H, Rothlin M. Aortic insufficiency. Circulation1968; 38:77–92. 285. Spagnuolo M, Kloth H, Taranta A, Doyle E, Pasternack B. Naturalhistory of rheumatic aortic regurgitation: criteria predictive of death,congestive heart failure, and angina in young patients. Circulation1971; 44:368–80. 286. Rapaport E. Natural history of aortic and mitral valve disease. Am JCardiol 1975; 35:221–7. 287. Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of patientswith heart failure and unoperated severe aortic valvular regurgitationand relation to ejection fraction. Am J Cardiol 1994; 74:286–8. 288. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, SewardJB, Tajik AJ. Mortality and morbidity of aortic regurgitation inclinical practice: a longterm follow-up study. Circulation 1999; 99:1851–7. 289. Parker E, Craige E, Hood WP Jr. The Austin Flint murmur and thea wave of the apexcardiogram in aortic regurgitation. Circulation1971; 43:349 –59. 290. Fortuin NJ, Craige E. On the mechanism of the Austin Flintmurmur. Circulation 1972; 45:558–0. 291. Harvey WP, Corrado MA, Perloff JK. “Right-sided” murmurs ofaortic insufficiency (diastolic murmurs better heard to the right ofthe sternum rather than to the left). Am J Med Sci 1963; 245:533–43. 292. Teague SM, Heinsimer JA, Anderson JL, et al. Quantification ofaortic regurgitation utilizing continuous wave Doppler ultrasound.J Am Coll Cardiol 1986;8:592–9. 293. Labovitz AJ, Ferrara RP, Kern MJ, Bryg RJ, Mrosek DG, WilliamsGA. Quantitative evaluation of aortic insufficiency by continuouswave Doppler echocardiography. J Am Coll Cardiol 1986; 8:1341–7. 294. Xie GY, Berk MR, Smith MD, DeMaria AN. A simplified methodfor determining regurgitant fraction by Doppler echocardiographyin patients with aortic regurgitation. J Am Coll Cardiol 1994; 24:1041–5. 295. Borer JS, Bacharach SL, Green MV, et al. Exercise-induced leftventricular dysfunction in symptomatic and asymptomatic patientswith aortic regurgitation: assessment with radionuclide cineangiography.Am J Cardiol 1978;42:351–7. 296. Lewis SM, Riba AL, Berger HJ, et al. Radionuclide angiographicexercise left ventricular performance in chronic aortic regurgitation:relationship to resting echographic ventricular dimensions andsystolic wall stress index. Am Heart J 1982; 103:498 –504. 297. Huxley RL, Gaffney FA, Corbett JR, et al. Early detection of leftventricular dysfunction in chronic aortic regurgitation as assessed bycontrast angiography, echocardiography, and rest and exercise scintigraphy.Am J Cardiol 1983; 51:1542–50. 298. Iskandrian AS, Hakki AH, Manno B, Amenta A, Kane SA. Leftventricular function in chronic aortic regurgitation. J Am CollCardiol 1983; 1:1374–80. 299. Gerson MC, Engel PJ, Mantil JC, Bucher PD, Hertzberg VS, Adolph RJ. Effects of dynamic and isometric exercise on theradionuclide-determined regurgitant fraction in aortic insufficiency. J Am Coll Cardiol 1984; 3:98–106. 300. Goldman ME, Packer M, Horowitz SF, et al. Relation betweenexerciseinduced changes in ejection fraction and systolic loadingconditions at rest in aortic regurgitation. J Am Coll Cardiol1984; 3:924 –9. 301. Greenberg B, Massie B, Thomas D, et al. Association between theexercise ejection fraction response and systolic wall stress in patientswith chronic aortic insufficiency. Circulation 1985; 71:458–65. 302. Massie BM, Kramer BL, Loge D, et al. Ejection fraction responseto supine exercise in asymptomatic aortic regurgitation: relation tosimultaneous hemodynamic measurements. J Am Coll Cardiol1985; 5:847–55. 303. Wilson RA, Greenberg BH, Massie BM, et al. Left ventricularresponse to submaximal and maximal exercise in asymptomaticaortic regurgitation. Am J Cardiol 1988; 62:606 –10. 304. Bolen JL, Alderman EL. Hemodynamic consequences of afterloadreduction in patients with chronic aortic regurgitation. Circulation1976; 53:879–83. 305. Miller RR, Vismara LA, DeMaria AN, Salel AF, Mason DT.Afterload reduction therapy with nitroprusside in severe aorticregurgitation: improved cardiac performance and reduced regurgitantvolume. Am J Cardiol 1976; 38:564–7. 306. Greenberg BH, DeMots H, Murphy E, Rahimtoola S. Beneficialeffects of hydralazine on rest and exercise hemodynamics in patientswith chronic severe aortic insufficiency. Circulation 1980; 62:49 –55. 307. Greenberg BH, DeMots H, Murphy E, Rahimtoola SH. Mechanismfor improved cardiac performance with arteriolar dilators inaortic insufficiency. Circulation 1981; 63:263– 8. 308. Fioretti P, Benussi B, Scardi S, Klugmann S, Brower RW, CameriniF. Afterload reduction with nifedipine in aortic insufficiency. Am JCardiol 1982; 49:1728 –32 309. Shen WF, Roubin GS, Hirasawa K, et al. Noninvasive assessmentof acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. J Am CollCardiol 1984; 4:902–7. 309 310. Scognamiglio R, Fasoli G, Visintin L, Dalla-Volta S. Effects ofunloading and positive inotropic interventions on left ventricularfunction in asymptomatic patients with chronic severe aortic insuf-ficiency. Clin Cardiol 1987; 10:804 –10. 311. Rothlisberger C, Sareli P, Wisenbaugh T. Comparison of singledosenifedipine and captopril for chronic severe aortic regurgitation.Am J Cardiol 1993;72:799–804. 312. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitantlesions of the mitral and aortic valves. J Am Coll Cardiol 1996; 28:1083–91. 313. Sondergaard L, Aldershvile J, Hildebrandt P, Kelbaek H, StahlbergF, Thomsen C. Vasodilatation with felodipine in chronic asymptomaticaortic regurgitation. Am Heart J 2000; 139:667–74. 314. Scognamiglio R, Fasoli G, Ponchia A, Dalla-Volta S. Long-termnifedipine unloading therapy in asymptomatic patients with chronicsevere aortic regurgitation. J Am Coll Cardiol 1990; 16:424 –9. 315. Wisenbaugh T, Sinovich V, Dullabh A, Sareli P. Six month pilotstudy of captopril for mildly symptomatic, severe isolated mitral andisolated aortic regurgitation. J Heart Valve Dis 1994; 3:197–204. 316. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronicasymptomatic aortic regurgitation: enalapril versus hydralazine therapy.J Am Coll Cardiol 1994;24:1046 –53. 317. Schon HR, Dorn R, Barthel P, Schomig A. Effects of 12 monthsquinapril therapy in asymptomatic patients with chronic aorticregurgitation. J Heart Valve Dis 1994; 3:500 –9. 318. Keller AM, Peshock RM, Malloy CR, et al. In vivo measurement ofmyocardial mass using nuclear magnetic resonance imaging. J AmColl Cardiol 1986; 8:113–7. 319. Van Rossum AC, Visser FC, Sprenger M, Van Eenige MJ, Valk J,Roos JP. Evaluation of magnetic resonance imaging for determinationof left ventricular ejection fraction and comparison withangiography. Am J Cardiol 1988; 62:628 –33. 320. Buser PT, Auffermann W, Holt WW, et al. Noninvasive evaluationof global left ventricular function with use of cine nuclear magneticresonance. J Am Coll Cardiol 1989; 13:1294 –300. 321. Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, PohostGM. Left ventricular volume measurement using cardiac axisnuclear magnetic resonance imaging: validation by calibrated ventricularangiography. Circulation 1990; 82:154–63. 322. Benjelloun H, Cranney GB, Kirk KA, Blackwell GG, Lotan CS, Pohost GM. Interstudy reproducibility of biplane cine nuclearmagnetic resonance measurements of left ventricular function. Am JCardiol 1991; 67:1413–20 323. Sechtem U, Pflugfelder PW, Cassidy MM, et al. Mitral or aorticregurgitation: quantification of regurgitant volumes with cine MRimaging. Radiology 1988; 167:425–30. 324. Dulce MC, Mostbeck GH, O’Sullivan M, Cheitlin M, Caputo GR, Higgins CB. Severity of aortic regurgitation: interstudy reproducibilityof measurements with velocity-encoded cine MR imaging.Radiology 1992; 185:235– 40. 325. Fujita N, Chazouilleres AF, Hartiala JJ, et al. Quantification ofmitral regurgitation by velocity-encoded cine nuclear magneticresonance imaging. J Am Coll Cardiol 1994; 23:951– 8. 326. Walker PG, Oyre S, Pedersen EM, Houlind K, Guenet FS, Yoganathan AP. A new control volume method for calculatingvalvular regurgitation. Circulation 1995; 92:579–86. 310 311 327. Hundley WG, Li HF, Willard JE, et al. Magnetic resonanceimaging assessment of the severity of mitral regurgitation: comparisonwith invasive techniques. Circulation 1995; 92:1151– 8. 328. Bonow RO, Nikas D, Elefteriades JA. Valve replacement forregurgitant lesions of the aortic or mitral valve in advanced leftventricular dysfunction. Cardiol Clin 1995; 13:73– 83, 85. 329. Rahimtoola SH. Valve replacement should not be performed in allasymptomatic patients with severe aortic incompetence. J ThoracCardiovasc Surg 1980; 79:163–72. 330. Nishimura RA, McGoon MD, Schaff HV, Giuliani ER. Chronicaortic regurgitation: indications for operation—1988. Mayo ClinProc 1988; 63:270–80. 331. Carabello BA. The changing unnatural history of valvular regurgitation.Ann Thorac Surg 1992; 53:191–9. 332. Gaasch WH, Sundaram M, Meyer TE. Managing asymptomaticpatients with chronic aortic regurgitation. Chest 1997; 111:1702–9. 333. Bonow RO. Chronic aortic regurgitation: role of medical therapyand optimal timing for surgery. Cardiol Clin 1998; 16:449–61. 334. Borer JS, Bonow RO. Contemporary approach to aortic and mitralregurgitation. Circulation 2003; 108:2432– 8. 335. Enriquez-Sarano M, Tajik AJ. Clinical practice: aortic regurgitation.N Engl J Med 2004; 351:1539–46. 336. Turina J, Turina M, Rothlin M, Krayenbuehl HP. Improved latesurvival in patients with chronic aortic regurgitation by earlieroperation. Circulation 1984; 70:I147–52. 337. Gaasch WH, Schick EC. Symptoms and left ventricular size andfunction in patients with chronic aortic regurgitation. J Am CollCardiol 2003; 41:1325– 8. 338. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR,Seward JB. Surgery for aortic regurgitation in women: contrastingindications and outcomes compared with men. Circulation 1996; 94:2472– 8. 339. Mathew RK, Gaasch WH, Guilmette NE, Schick EC, Labib SB.Anthropometric normalization of left ventricular size in chronicmitral regurgitation. Am J Cardiol 2003;91:762– 4. 340. Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distributionand categorization of echocardiographic measurements inrelation to reference limits: the Framingham Heart Study: formulationof a height- and sex-specific classification and its prospectivevalidation. Circulation 1997; 96:1863–73. 341. Gash AK, Carabello BA, Kent RL, Frazier JA, Spann JF. Leftventricular performance in patients with coexistent mitral stenosisand aortic insufficiency. J Am Coll Cardiol 1984; 3:703–11. 342. Olson LJ, Subramanian R, Edwards WD. Surgical pathology ofpure aortic insufficiency: a study of 225 cases. Mayo Clin Proc1984; 59:835– 41. 343. Lindsay J Jr, Beall AC Jr, DeBakey ME. Diagnosis and treatment ofdiseases of the aorta. In: Schlant R, Alexander RW, editors. Hurst’sThe Heart. 9th edition. New York, NY: McGraw Hill, 1998:2461–82. 344. Ergin MA, Spielvogel D, Apaydin A, et al. Surgical treatment of thedilated ascending aorta: when and how? Ann Thorac Surg 1999; 67:1834–9. 345. Boucher CA, Bingham JB, Osbakken MD, et al. Early changes inleft ventricular size and function after correction of left ventricularvolume overload. Am J Cardiol 1981; 47:991–1004. 346. Schuler G, Peterson KL, Johnson AD, et al. Serial noninvasiveassessment of left ventricular hypertrophy and function after surgicalcorrection of aortic regurgitation. Am J Cardiol 1979; 44:585–94. 347. Elayda MA, Hall RJ, Reul RM, et al. Aortic valve replacement inpatients 80 years and older: operative risks and long-term results.Circulation 1993;88:II11– 6. 348. Nataatmadja M, West M, West J, et al. Abnormal extracellularmatrix protein transport associated with increased apoptosis ofvascular smooth muscle cells in Marfan syndrome and bicuspidaortic valve thoracic aortic aneurysm. Circulation 2003; 108 Suppl1:II329 –34. 349. Braverman AC, Guven H, Beardslee MA, Makan M, Kates AM,Moon MR. The bicuspid aortic valve. Curr Probl Cardiol 2005; 30:470–522. 350. Hahn RT, Roman MJ, Mogtader AH, Devereux RB. Associationof aortic dilation with regurgitant, stenotic and functionally normalbicuspid aortic valves. J Am Coll Cardiol 1992; 19:283– 8. 351. Nistri S, Sorbo MD, Marin M, Palisi M, Scognamiglio R, ThieneG. Aortic root dilatation in young men with normally functioningbicuspid aortic valves. Heart 1999; 82:19 –22. 352. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE,Sutton MG. Bicuspid aortic valves are associated with aorticdilatation out of proportion to coexistent valvular lesions. Circulation2000; 102:III35–9. 353. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J.Clinical and pathophysiological implications of a bicuspid aorticvalve. Circulation 2002; 106:900–4. 354. Ferencik M, Pape LA. Changes in size of ascending aorta and aorticvalve function with time in patients with congenitally bicuspid aorticvalves. Am J Cardiol 2003; 92:43– 6. 355. Roberts CS, Roberts WC. Dissection of the aorta associated withcongenital malformation of the aortic valve. J Am Coll Cardiol1991; 17:712– 6. 356. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture ordissection rates for thoracic aortic aneurysms: simple predictionbased on size. Ann Thorac Surg 2002; 73:17–27. 357. Svensson LG, Kim KH, Lytle BW, Cosgrove DM. Relationship ofaortic crosssectional area to height ratio and the risk of aorticdissection in patients with bicuspid aortic valves. J Thorac Cardiovasc Surg 2003; 126:892–3. 358. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002; 74:S1877– 80. 359. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aorticdilatation and the benefit of long-term beta-adrenergic blockade inMarfan’s syndrome. N Engl J Med 1994; 330:1335– 41. 360. Roman MJ, Devereux RB, Kramer-Fox R, O’Loughlin J. Two dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64:507–12. 361. Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC. Suggested standards for reporting on arterial aneurysms: Subcommittee on Reporting Standards for Arterial Aneurysms, AdHoc Committee on Reporting Standards, Society for VascularSurgery and North American Chapter, International Society forCardiovascular Surgery. J Vasc Surg 1991; 13:452– 8. 362. David TE, Armstrong S, Ivanov J, Webb GD. Aortic valve sparingoperations: an update. Ann Thorac Surg 1999; 67:1840 –2. 312 313 363. Kallenbach K, Hagl C, Walles T, et al. Results of valve-sparingaortic root reconstruction in 158 consecutive patients. Ann ThoracSurg 2002; 74:2026 –32. 364. Zehr KJ, Orszulak TA, Mullany CJ, et al. Surgery for aneurysms ofthe aortic root: a 30–year experience. Circulation 2004; 110:1364–71. 365. McDonald ML, Smedira NG, Blackstone EH, Grimm RA, LytleBW, Cosgrove DM. Reduced survival in women after valve surgeryfor aortic regurgitation: effect of aortic enlargement and late aorticrupture. J Thorac Cardiovasc Surg 2000; 119:1205–12. 366. Borger MA, Preston M, Ivanov J, et al. Should the ascending aortabe replaced more frequently in patients with bicuspid aortic valvedisease? J Thorac Cardiovasc Surg 2004; 128:677– 83. 367. Wood P. An appreciation of mitral stenosis, I: clinical features. BrMed J 1954; 4870:1051– 63. 368. Rowe JC, Bland EF, Sprague HB, White PD. The course of mitralstenosis without surgery: ten- and twenty-year perspectives. AnnIntern Med 1960; 52:741–9. 369. Olesen KH. The natural history of 271 patients with mitral stenosisunder medical treatment. Br Heart J 1962; 24:349 –57. 370. Roberts WC, Perloff JK. Mitral valvular disease: a clinicopathologicsurvey of the conditions causing the mitral valve to functionabnormally. Ann Intern Med 1972; 77:939 –75. 371. Rusted IE, Scheifley CH, Edwards JE. Studies of the mitral valve, II: certain anatomic features of the mitral valve and associatedstructures in mitral stenosis. Circulation 1956; 14:398–406. 372. Braunwald E, Moscovitz HL, Mram SS, et al. The hemodynamicsof the left side of the heart as studied by simultaneous left atrial, leftventricular, and aortic pressures; particular reference to mitralstenosis. Circulation 1955; 12:69–81. 373. Snopek G, Pogorzelska H, Rywik TM, Browarek A, Janas J,Korewicki J. Usefulness of endothelin-1 concentration in capillaryblood in patients with mitral stenosis as a predictor of regression ofpulmonary hypertension after mitral valve replacement or valvuloplasty.Am J Cardiol 2002;90:188 –9. 374. Hugenholtz PG, Ryan TJ, Stein SW, Belmann WH. The spectrumof pure mitral stenosis: hemodynamic studies in relation to clinicaldisability. Am J Cardiol 1962; 10:773– 84. 375. Kasalicky J, Hurych J, Widimsky J, Dejdar R, Metys R, Stanek V.Left heart haemodynamics at rest and during exercise in patientswith mitral stenosis. Br Heart J 1968; 30:188 –95. 376. Gorlin R. The mechanism of the signs and symptoms of mitral valvedisease. Br Heart J 1954; 16:375– 80. 377. Wood P. An appreciation of mitral stenosis, II: investigations andresults. Br Med J 1954; 4871:1113–24. 378. Halperin JL, Brooks KM, Rothlauf EB, Mindich BP, Ambrose JA, Teichholz LE. Effect of nitroglycerin on the pulmonary venousgradient in patients after mitral valve replacement. J Am CollCardiol 1985; 5:34 –9. 379. Halperin JL, Rothlauf EB, Brooks KM, Mindich BP, Ambrose JA.Effect of nitroglycerin during hemodynamic estimation of valveorifice in patients with mitral stenosis. J Am Coll Cardiol 1987; 10:342–8. 380. Selzer A, Cohn KE. Natural history of mitral stenosis: a review.Circulation 1972; 45:878 –90. 381. Munoz S, Gallardo J, Diaz-Gorrin JR, Medina O. Influence ofsurgery on the natural history of rheumatic mitral and aortic valvedisease. Am J Cardiol 1975; 35:234–42. 382. Ward C, Hancock BW. Extreme pulmonary hypertension caused bymitral valve disease: natural history and results of surgery. Br Heart J1975; 37:74–8. 383. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy andthe new demographics of mitral stenosis. JAMA 1993; 270:1731– 6. 384. Tuzcu EM, Block PC, Griffin BP, Newell JB, Palacios IF. Immediateand longterm outcome of percutaneous mitral valvotomy inpatients 65 years and older. Circulation 1992; 85:963–71. 385. Dubin AA, March HW, Cohn K, Selzer A. Longitudinal hemodynamicand clinical study of mitral stenosis. Circulation 1971; 44:381–9. 386. Gordon SP, Douglas PS, Come PC, Manning WJ. Twodimensionaland Doppler echocardiographic determinants of thenatural history of mitral valve narrowing in patients with rheumaticmitral stenosis: implications for follow-up. J Am Coll Cardiol1992; 19:968 –73. 387. Craige E. Phonocardiographic studies in mitral stenosis. N EnglJ Med 1957; 257:650–4. 388. Henry WL, Griffith JM, Michaelis LL, McIntosh CL, MorrowAG, Epstein SE. Measurement of mitral orifice area in patientswith mitral valve disease by real-time, two-dimensional echocardiography.Circulation 1975;51:827–31. 389. Holen J, Aaslid R, Landmark K, Simonsen S. Determination ofpressure gradient in mitral stenosis with a non-invasive ultrasoundDoppler technique. Acta Med Scand 1976; 199:455– 60. 390. Nichol PM, Gilbert BW, Kisslo JA. Two-dimensional echocardiographicassessment of mitral stenosis. Circulation 1977; 55:120–8. 391. Hatle L, Brubakk A, Tromsdal A, Angelsen B. Noninvasiveassessment of pressure drop in mitral stenosis by Doppler ultrasound.Br Heart J 1978; 40:131– 40. 392. Wann LS, Weyman AE, Feigenbaum H, Dillon JC, Johnston KW, Eggleton RC. Determination of mitral valve area by cross-sectionalechocardiography. Ann Intern Med 1978; 88:337– 41. 393. Martin RP, Rakowski H, Kleiman JH, Beaver W, London E, PoppRL. Reliability and reproducibility of two dimensional echocardiographmeasurement of the stenotic mitral valve orifice area. Am JCardiol 1979; 43:560–8. 394. Reid CL, McKay CR, Chandraratna PA, Kawanishi DT, RahimtoolaSH. Mechanisms of increase in mitral valve area and influenceof anatomic features in double-balloon, catheter balloon valvuloplastyin adults with rheumatic mitral stenosis: a Doppler andtwo-dimensional echocardiographic study. Circulation 1987; 76:628–36. 395. Rediker DE, Block PC, Abascal VM, Palacios IF. Mitral balloonvalvuloplasty for mitral restenosis after surgical commissurotomy.J Am Coll Cardiol 1988; 11:252– 6. 396. Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloonmitral valvotomy with the Inoue single-balloon catheter: commissuralmorphology as a determinant of outcome. J Am Coll Cardiol1993; 21:390 –7. 397. Iung B, Cormier B, Ducimetiere P, et al. Functional results 5 yearsafter successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol1996; 27:407–14. 314 315 398. Cannan CR, Nishimura RA, Reeder GS, et al. Echocardiographicassessment of commissural calcium: a simple predictor of outcomeafter percutaneous mitral balloon valvotomy. J Am Coll Cardiol1997; 29:175– 80. 399. Reid CL, Chandraratna PA, Kawanishi DT, Kotlewski A, RahimtoolaSH. Influence of mitral valve morphology on double-ballooncatheter balloon valvuloplasty in patients with mitral stenosis: analysis of factors predicting immediate and 3-month results.Circulation 1989; 80:515–24. 400. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF.Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanismof dilatation. Br Heart J 1988; 60:299 –308. 401. Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment ofatrioventricular pressure half-time by Doppler ultrasound. Circulation1979; 60:1096 –104. 402. Nakatani S, Masuyama T, Kodama K, Kitabatake A, Fujii K,Kamada T. Value and limitations of Doppler echocardiography inthe quantification of stenotic mitral valve area: comparison of thepressure half-time and the continuity equation methods. Circulation1988;77:78–85. 403. Thomas JD, Wilkins GT, Choong CY, et al. Inaccuracy of mitralpressure halftime immediately after percutaneous mitral valvotomy.Dependence on transmitral gradient and left atrial and ventricularcompliance. Circulation 1988;78:980 –93. 404. Flachskampf FA, Weyman AE, Guerrero JL, Thomas JD. Influenceof orifice geometry and flow rate on effective valve area: an invitro study. J Am Coll Cardiol 1990;15:1173– 80. 405. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Dopplerdetermination of right ventricular pressure: a simultaneous Dopplercatheterizationstudy in 127 patients. J Am Coll Cardiol 1985;6:750–6. 406. Himelman RB, Stulbarg M, Kircher B, et al. Noninvasive evaluationof pulmonary artery pressure during exercise by saline-enhancedDoppler echocardiography in chronic pulmonary disease. Circulation1989; 79:863–71. 407. Tamai J, Nagata S, Akaike M, et al. Improvement in mitral flowdynamics during exercise after percutaneous transvenous mitralcommissurotomy: noninvasive evaluation using continuous waveDoppler technique. Circulation 1990;81:46 –51. 408. Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitralgradient and pulmonary artery pressure in patients with mitralstenosis or a prosthetic mitral valve: a Doppler echocardiographicstudy. J Am Coll Cardiol 1991; 17:1520–6. 409. Cheriex EC, Pieters FA, Janssen JH, de Swart H, Palmans-Meulemans A. Value of exercise Doppler-echocardiography inpatients with mitral stenosis. Int J Cardiol 1994; 45:219 –26. 410. Okay T, Deligonul U, Sancaktar O, Kozan O. Contribution ofmitral valve reserve capacity to sustained symptomatic improvementafter balloon valvulotomy in mitral stenosis: implications for restenosis.J Am Coll Cardiol 1993; 22:1691– 6. 411. Nakhjavan FK, Katz MR, Maranhao V, Goldberg H. Analysis ofinfluence of catecholamine and tachycardia during supine exercise inpatients with mitral stenosis and sinus rhythm. Br Heart J 1969; 31:753–61. 412. Bhatia ML, Shrivastava S, Roy SB. Immediate haemodynamiceffects of a beta adrenergic blocking agent—propranolo—in mitralstenosis at fixed heart rates. Br Heart J 1972; 34:638–4. 413. Alan S, Ulgen MS, Ozdemir K, Keles T, Toprak N. Reliability andefficacy of metoprolol and diltiazem in patients having mild tomoderate mitral stenosis with sinus rhythm. Angiology 2002; 53:575–81. 414. Cieslewicz G, Juszczyk G, Foremny J, et al. Inhaled corticosteroidimproves bronchial reactivity and decreases symptoms in patientswith mitral stenosis. Chest 1998; 114:1070–4. 415. Beiser GD, Epstein SE, Stampfer M, Robinson B, Braunwald E.Studies on digitalis, XVII: effects of ouabain on the hemodynamicresponse to exercise in patients with mitral stenosis in normal sinusrhythm. N Engl J Med 1968; 278:131–7. 416. Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, WalkerE. Systemic embolism in mitral valve disease. Br Heart J 1970; 32:26–34. 417. Abernathy WS, Willis PW III. Thromboembolic complications ofrheumatic heart disease. Cardiovasc Clin 1973; 5:131–75. 418. Daley R, Mattingly TW, Holt CL, Bland EF, White PD. Systemicarterial embolism in rheumatic heart disease. Am Heart J 1951; 42:566–81. 419. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotictherapy in atrial fibrillation. Chest 1992; 102:426S–33S. 420. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS.Transesophageal echocardiographically facilitated early cardioversionfrom atrial fibrillation using short-term anticoagulation: finalresults of a prospective 4.5-year study. J Am Coll Cardiol 1995; 25:1354–61. 421. Adams GF, Merrett JD, Hutchinson WM, Pollock AM. Cerebralembolism and mitral stenosis: survival with and without anticoagulants.J Neurol Neurosurg Psych 1974; 37:378–83. 422. Krasuski RA, Assar MD, Wang A, et al. Usefulness of percutaneousballoon mitral commissurotomy in preventing the development ofatrial fibrillation in patients with mitral stenosis. Am J Cardiol2004; 93:936 –9. 423. Levine HJ, Pauker SG, Eckman MH. Antithrombotic therapy invalvular heart disease. Chest 1995; 108:360S–70S. 424. Caplan LR, D’Cruz I, Hier DB, Reddy H, Shah S. Atrial size, atrialfibrillation, and stroke. Ann Neurol 1986; 19:158–61. 425. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation1991; 84:527–39. 426. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in theprevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial FibrillationInvestigators. N Engl J Med 1992; 327:1406 –12. 427. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for preventionof thromboembolic events in valvular heart disease: StudyGroup of the Working Group on Valvular Heart Disease of theEuropean Society of Cardiology. Eur Heart J 1995; 16:1320 –30. 428. Kellogg F, Liu CK, Fishman IW, Larson R. Systemic and pulmonaryemboli before and after mitral commissurotomy. Circulation1961; 24:263– 6. 429. Deverall PB, Olley PM, Smith DR, Watson DA, Whitaker W.Incidence of systemic embolism before and after mitral valvotomy.Thorax 1968;23:530–6. 430. Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH.Predictors of systemic embolism in patients with mitral stenosis: aprospective study. Ann Intern Med 1998; 128:885–9. 316 431. Gorlin R, Sawyer CG, Haynes FW, Goodale WT, Dexter L.Effects of exercise on circulatory dynamics in mitral stenosis, III.Am Heart J 1951; 41:192–203. 432. Harvey RM, Ferrer I, Samet P, et al. Mechanical and myocardialfactors in rheumatic heart disease with mitral stenosis. Circulation1955; 11:531–51. 433. Aviles RJ, Nishimura RA, Pellikka PA, Andreen KM, Holmes DRJr. Utility of stress Doppler echocardiography in patients undergoing percutaneous mitral balloon valvotomy. J Am Soc Echocardiogr2001; 14:676–81. 434. Nishimura RA, Rihal CS, Tajik AJ, Holmes DR Jr. Accuratemeasurement of the transmitral gradient in patients with mitralstenosis: a simultaneous catheterization and Doppler echocardiographicstudy. J Am Coll Cardiol 1994; 24:152– 8. 435. Dahl JC, Winchell P, Borden CW. Mitral stenosis: a long termpostoperative follow-up. Arch Intern Med 1967; 119:92–7. 436. Ellis LB, Singh JB, Morales DD, Harken DE. Fifteen- to twentyyearstudy of one thousand patients undergoing closed mitralvalvuloplasty. Circulation 1973; 48:357– 64. 437. John S, Bashi VV, Jairaj PS, et al. Closed mitral valvotomy: earlyresults and long-term follow-up of 3724 consecutive patients.Circulation 1983; 68:891– 6. 438. Finnegan JO, Gray DC, MacVaugh H III, Joyner CR, Johnson J.The open approach to mitral commissurotomy. J Thorac CardiovascSurg 1974; 67:75– 82. 439. Mullin MJ, Engelman RM, Isom OW, Boyd AD, Glassman E, Spencer FC. Experience with open mitral commissurotomy in 100consecutive patients. Surgery 1974; 76:974–82. 440. Halseth WL, Elliott DP, Walker EL, Smith EA. Open mitralcommissurotomy: a modern re-evaluation. J Thorac CardiovascSurg 1980; 80:842– 8. 441. Gross RI, Cunningham JN Jr, Snively SL, et al. Long-term resultsof open radical mitral commissurotomy: ten year follow-up study of202 patients. Am J Cardiol 1981; 47:821–5. 442. Garcia-Fernandez MA, Perez-David E, Quiles J, et al. Role of leftatrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study.J Am Coll Cardiol 2003; 42:1253– 8. 443. Cribier A, Eltchaninoff H, Koning R, et al. Percutaneous mechanicalmitral commissurotomy with a newly designed metallic valvulotome:immediate results of the initial experience in 153 patients.Circulation 1999;99:793–9. 444. Multicenter experience with balloon mitral commissurotomy: NHLBI Balloon Valvuloplasty Registry Report on immediate and30-day follow-up results: the National Heart, Lung, and BloodInstitute Balloon Valvuloplasty Registry Participants. Circulation1992; 85:448–61. 445. Feldman T. Hemodynamic results, clinical outcome, and complicationsof Inoue balloon mitral valvotomy. Cathet Cardiovasc Diagn1994; 85 Suppl 2:2–7. 446. Cohen DJ, Kuntz RE, Gordon SP, et al. Predictors of long-termoutcome after percutaneous balloon mitral valvuloplasty. N EnglJ Med 1992; 327:1329 –35. 447. Complications and mortality of percutaneous balloon mitral commissurotomy:a report from the National Heart, Lung, and BloodInstitute Balloon Valvuloplasty Registry. Circulation 1992; 85:2014–24. 448. Orrange SE, Kawanishi DT, Lopez BM, Curry SM, RahimtoolaSH. Actuarial outcome after catheter balloon commissurotomy inpatients with mitral stenosis. Circulation 1997; 95:382–9. 317 449. Dean LS, Mickel M, Bonan R, et al. Four-year follow-up ofpatients undergoing percutaneous balloon mitral commissurotomy:a report from the National Heart, Lung, and Blood InstituteBalloon Valvuloplasty Registry. J Am Coll Cardiol 1996; 28:1452–7. 450. Iung B, Garbarz E, Michaud P, et al. Late results of percutaneousmitral commissurotomy in a series of 1024 patients: analysis of lateclinical deterioration: frequency, anatomic findings, and predictivefactors. Circulation 1999; 99:3272– 8. 451. Kang DH, Park SW, Song JK, et al. Long-term clinical andechocardiographic outcome of percutaneous mitral valvuloplasty:randomized comparison of Inoue and double-balloon techniques.J Am Coll Cardiol 2000;35:169 –5. 452. Tokmakoglu H, Vural KM, Ozatik MA, Cehreli S, Sener E,Tasdemir O. Closed commissurotomy versus balloon valvuloplastyfor rheumatic mitral stenosis. J Heart Valve Dis 2001; 10:281–7. 453. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC.Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predictlong-term outcome. Circulation 2002; 105:1465–71. 454. Palacios IF, Tuzcu ME, Weyman AE, Newell JB, Block PC.Clinical follow-up of patients undergoing percutaneous mitralballoon valvotomy. Circulation 1995; 91:671– 6. 455. Hernandez R, Banuelos C, Alfonso F, et al. Long-term clinical andechocardiographic follow-up after percutaneous mitral valvuloplastywith the Inoue balloon. Circulation 1999; 99:1580–6. 456. Patel JJ, Shama D, Mitha AS, et al. Balloon valvuloplasty versusclosed commissurotomy for pliable mitral stenosis: a prospectivehemodynamic study. J Am Coll Cardiol 1991; 18:1318 –22. 457. Turi ZG, Reyes VP, Raju BS, et al. Percutaneous balloon versussurgical closed commissurotomy for mitral stenosis: a prospective, randomized trial. Circulation 1991; 83:1179–85. 458. Arora R, Nair M, Kalra GS, Nigam M, Khalilullah M. Immediateand longterm results of balloon and surgical closed mitral valvotomy:a randomized comparative study. Am Heart J 1993; 125:1091–4. 459. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplastycompared with open surgical commissurotomy for mitralstenosis. N Engl J Med 1994; 331:961–7. 460. Ben Farhat M, Ayari M, Maatouk F, et al. Percutaneous balloonversus surgical closed and open mitral commissurotomy: seven-yearfollow-up results of a randomized trial. Circulation 1998; 97:245–50. 461. Cotrufo M, Renzulli A, Ismeno G, et al. Percutaneous mitralcommissurotomy versus open mitral commissurotomy: a comparativestudy. Eur J Cardiothorac Surg 1999; 15:646 –51. 462. Padial LR, Freitas N, Sagie A, et al. Echocardiography can predictwhich patients will develop severe mitral regurgitation after percutaneousmitral valvulotomy. J Am Coll Cardiol 1996; 27:1225–31. 463. Silaruks S, Thinkhamrop B, Tantikosum W, Wongvipaporn C,Tatsanavivat P, Klungboonkrong V. A prognostic model for predictingthe disappearance of left atrial thrombi among candidates forpercutaneous transvenous mitral commissurotomy. J Am Coll Cardiol2002; 39:886 –91. 464. Padial LR, Abascal VM, Moreno PR, Weyman AE, Levine RA, Palacios IF. Echocardiography can predict the development ofsevere mitral regurgitation 318 319 after percutaneous mitral valvuloplasty bythe Inoue technique. Am J Cardiol 1999; 83:1210 –3. 465. Post JR, Feldman T, Isner J, Herrmann HC. Inoue balloon mitralvalvotomy in patients with severe valvular and subvalvular deformity.J Am Coll Cardiol 1995; 25:1129 –36. 466. Wu ZK, Sun PW, Zhang X, Zhong FT, Tong CW, Lu K.Superiority of mitral valve replacement with preservation of subvalvularstructure to conventional replacement in severe rheumaticmitral valve disease: a modified technique and results of one-yearfollow up. J Heart Valve Dis 2000; 9:616 –22. 467. David TE. Artificial chordae. Semin Thorac Cardiovasc Surg2004; 16:161– 8. 468. Privitera S, Butany J, Silversides C, Leask RL, David TE. Artificialchordae tendinae: long-term changes. J Card Surg 2005; 20:90 –2. 469. Yasu T, Katsuki T, Ohmura N, et al. Delayed improvement inskeletal muscle metabolism and exercise capacity in patients withmitral stenosis following immediate hemodynamic amelioration bypercutaneous transvenous mitral commissurotomy. Am J Cardiol1996; 77:492–7. 470. Braunwald E, Braunwald NS, Ross JJ, Morrow AG. Effects ofmitral valve replacement on the pulmonary vascular dynamics ofpatients with pulmonary hypertension. N Engl J Med 1965; 273:509–7. 471. Dalen JE, Matloff JM, Evans GL, et al. Early reduction ofpulmonary vascular resistance after mitral-valve replacement.N Engl J Med 1967; 277:387–94. 472. McKay CR, Kawanishi DT, Kotlewski A, et al. Improvement inexercise capacity and exercise hemodynamics 3 months after doubleballoon,catheter balloon valvuloplasty treatment of patients withsymptomatic mitral stenosis. Circulation 1988; 77:1013–21. 473. Rihal CS, Schaff HV, Frye RL, Bailey KR, Hammes LN, HolmesDR Jr. Longterm follow-up of patients undergoing closed transventricularmitral commissurotomy: a useful surrogate for percutaneousballoon mitral valvuloplasty? J Am Coll Cardiol 1992; 20:781–6. 474. Mahoney PD, Loh E, Blitz LR, Herrmann HC. Hemodynamiceffects of inhaled nitric oxide in women with mitral stenosis andpulmonary hypertension. Am J Cardiol 2001; 87:188 –92. 475. Higgs LM, Glancy DL, O’Brien KP, Epstein SE, Morrow AG.Mitral restenosis: an uncommon cause of recurrent symptomsfollowing mitral commissurotomy. Am J Cardiol 1970; 26:34 –7. 476. Abascal VM, Wilkins GT, Choong CY, et al. Echocardiographicevaluation of mitral valve structure and function in patients followedfor at least 6 months after percutaneous balloon mitral valvuloplasty.J Am Coll Cardiol 1988;12:606 –15. 477. Jang IK, Block PC, Newell JB, Tuzcu EM, Palacios IF. Percutaneousmitral balloon valvotomy for recurrent mitral stenosis aftersurgical commissurotomy. Am J Cardiol 1995;75:601–5. 478. Rangel A, Chavez E, Murillo H, Ayala F. Immediate results of theInoue mitral valvotomy in patients with previous surgical mitralcommissurotomy: preliminary report. Arch Med Res 1998;29:159–63. 479. Gupta A, Lokhandwala YY, Satoskar PR, Salvi VS. Balloon mitralvalvotomy in pregnancy: maternal and fetal outcomes. J Am CollSurg 1998;187:409 –15. 480. Shaw TR, Sutaria N, Prendergast B. Clinical and haemodynamicprofiles of young, middle aged, and elderly patients with mitralstenosis undergoing mitral balloon valvotomy. Heart 2003;89:1430–6. 481. Freed LA, Benjamin EJ, Levy D, et al. Mitral valve prolapse in thegeneral population: the benign nature of echocardiographic featuresin the Framingham Heart Study. J Am Coll Cardiol 2002;40:1298–304. 482. Freed LA, Levy D, Levine RA, et al. Prevalence and clinicaloutcome of mitralvalve prolapse. N Engl J Med 1999;341:1–7. 483. Lucas RV Jr, Edwards JE. The floppy mitral valve. Curr ProblCardiol 1982;7:1– 48. 484. Shell WE, Walton JA, Clifford ME, Willis PW III. The familial occurrence of the syndrome of mid-late systolic click and latesystolic murmur. Circulation 1969;39:327–37. 485. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance ofmitral valve prolapse: effect of age and sex on gene expression. AnnIntern Med 1982;97:826 –32. 486. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus forautosomal dominant myxomatous mitral-valve prolapse to chromosome16p11.2- p12.1. Am J Hum Genet 1999;65:1242–51. 487. Freed LA, Acierno JS Jr, Dai D, et al. A focus for autosomaldominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 2003;72:1551–9. 488. Nesta F, Leyne M, Yosefy C, et al. New focus for autosomaldominant mitral valve prolapse on chromosome 13: clinical insightsfrom genetic studies. Circulation 2005;112:2022–30. 489. Leier CV, Call TD, Fulkerson PK, Wooley CF. The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. AnnIntern Med 1980;92:171– 8. 490. Schwarz T, Gotsman MS. Mitral valve prolapse in osteogenesisimperfecta. Isr J Med Sci 1981;17:1087– 8. 491. Lebwohl MG, Distefano D, Prioleau PG, Uram M, Yannuzzi LA,Fleischmajer R. Pseudoxanthoma elasticum and mitral-valve prolapse.N Engl J Med 1982;307:228 –31. 492. Rosenberg CA, Derman GH, Grabb WC, Buda AJ. Hypomastiaand mitralvalve prolapse: evidence of a linked embryologic andmesenchymal dysplasia. N Engl J Med 1983;309:1230 –2. 493. Avierinos JF, Gersh BJ, Melton LJ III, et al. Natural history ofasymptomatic mitral valve prolapse in the community. Circulation2002;106:1355– 61. 494. Chandraratna PA, Nimalasuriya A, Kawanishi D, Duncan P, RosinB, Rahimtoola SH. Identification of the increased frequency ofcardiovascular abnormalities associated with mitral valve prolapse bytwo-dimensional echocardiography. Am J Cardiol 1984;54:1283–5. 495. Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM,Tajik AJ. Echocardiographically documented mitral-valve prolapse:long-term followup of 237 patients. N Engl J Med 1985;313:1305–9. 496. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE.Identification of high-risk and low-risk subgroups of patients withmitral-valve prolapse. N Engl J Med 1989;320:1031– 6. 497. Takamoto T, Nitta M, Tsujibayashi T, Taniguchi K, Marumo F.The prevalence and clinical features of pathologically abnormalmitral valve leaflets (myxomatous mitral valve) in the mitral valveprolapse syndrome: an echocardiographic and pathological comparativestudy. J Cardiol Suppl 1991;25:75– 86. 498. Babuty D, Cosnay P, Breuillac JC, et al. Ventricular arrhythmiafactors in mitral valve prolapse. Pacing Clin Electrophysiol 1994;17:1090 –9. 499. Zuppiroli A, Mori F, Favilli S, et al. Arrhythmias in mitral valveprolapse: relation to anterior mitral leaflet thickening, clinicalvariables, and color Doppler echocardiographic parameters. AmHeart J 1994;128:919 –27. 500. Allen H, Harris A, Leatham A. Significance and prognosis of anisolated late systolic murmur: a 9- to 22-year follow-up. Br Heart J1974;36:525–32. 501. Mills P, Rose J, Hollingsworth J, Amara I, Craige E. Long-termprognosis of mitral-valve prolapse. N Engl J Med 1977;297:13– 8. 502. Fontana ME, Sparks EA, Boudoulas H, Wooley CF. Mitral valveprolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol1991;16:309 –75. 503. Clemens JD, Horwitz RI, Jaffe CC, Feinstein AR, Stanton BF. Acontrolled evaluation of the risk of bacterial endocarditis in personswith mitral-valve prolapse. N Engl J Med 1982;307:776–81. 504. Devereux RB, Frary CJ, Kramer-Fox R, Roberts RB, Ruchlin HS.Cost-effectiveness of infective endocarditis prophylaxis for mitralvalve prolapse with or without a mitral regurgitant murmur. Am JCardiol 1994;74:1024 –9. 505. Wilson LA, Keeling PW, Malcolm AD, Russel RW, Webb-PeploeMM. Visual complications of mitral leaflet prolapse. Br Med J1977;2:86–8. 506. Barnett HJ, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ,Nichol PM. Further evidence relating mitral-valve prolapse tocerebral ischemic events. N Engl J Med 1980;302:139–44. 507. Cheitlin MD, Byrd RC. Prolapsed mitral valve: the commonestvalve disease? Curr Probl Cardiol 1984;8:1–54. 508. Devereux RB, Hawkins I, Kramer-Fox R, et al. Complications ofmitral valve prolapse: disproportionate occurrence in men and olderpatients. Am J Med 1986;81:751– 8. 509. Duren DR, Becker AE, Dunning AJ. Long-term follow-up ofidiopathic mitral valve prolapse in 300 patients: a prospective study.J Am Coll Cardiol 1988;11:42–7. 510. Boudoulas H, Kobash BH, Wooley CF. Mitral valve prolapse: aheterogeneous disorder. Primary Cardiology 1991;17:29–43. 511. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ,Devereux RB. Natural history of mitral valve prolapse. Am J Cardiol1995;75:1028 –32. 512. Vohra J, Sathe S, Warren R, Tatoulis J, Hunt D. Malignantventricular arrhythmias in patients with mitral valve prolapse andmild mitral regurgitation. Pacing Clin Electrophysiol 1993;16:387–93. 513. Martini B, Basso C, Thiene G. Sudden death in mitral valveprolapse with Holter monitoring-documented ventricular fibrillation:evidence of coexisting arrhythmogenic right ventricular cardiomyopathy.Int J Cardiol 1995;49:274–8. 514. Puddu PE, Pasternac A, Tubau JF, Krol R, Farley L, de ChamplainJ. QT interval prolongation and increased plasma catecholaminelevels in patients with mitral valve prolapse. Am Heart J 1983;105:422–8. 515. O’Rourke RA, Crawford MH. The systolic click-murmur syndrome:clinical recognition and management. Curr Probl Cardiol1976;1:1– 60. 516. Shah PM. Echocardiographic diagnosis of mitral valve prolapse.J Am Soc Echocardiogr 1994;7:286 –93. 517. Krivokapich J, Child JS, Dadourian BJ, Perloff JK. Reassessment ofechocardiographic criteria for diagnosis of mitral valve prolapse.Am J Cardiol 1988;61:131–5. 518. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcomeof mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417–23. 321 322 519. Bankier B, Littman AB. Psychiatric disorders and coronary heartdisease in women—a still neglected topic: review of the literaturefrom 1971 to 2000. Psychother Psychosom 2002;71:133– 40. 520. Barnett HJ, Jones MW, Boughner DR, Kostuk WJ. Cerebralischemic events associated with prolapsing mitral valve. Arch Neurol1976;33:777– 82. 521. Barletta GA, Gagliardi R, Benvenuti L, Fantini F. Cerebralischemic attacks as a complication of aortic and mitral valveprolapse. Stroke 1985;16:219 –3. 522. Boughner DR, Barnett HJ. The enigma of the risk of stroke inmitral valve prolapse. Stroke 1985;16:175–7. 523. Winkle RA, Lopes MG, Goodman DJ, Fitzgerald JW, SchroederJS, Harrison DC. Propranolol for patients with mitral valve prolapse.Am Heart J 1977;93:422–7. 524. Schaal SF. Ventricular arrhythmias in patients with mitral valveprolapse. Cardiovasc Clin 1992;22:307–16. 524 a. Sacco RL, Adams R, Albers G, et al. Guidelines for the preventionof stroke in patients with ischemic stroke or transient ischemicattacks. A statement for healthcare professionals from the AmericanHeart Association Council on Stroke. Stroke 2006;37:577– 617. 525. Preliminary report of the Stroke Prevention in Atrial FibrillationStudy. N Engl J Med 1990;322:863– 8. 526. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of theasymptomatic/minimally symptomatic patient with severe mitralregurgitation secondary to mitral valve prolapse and normal rightand left ventricular performance. Am J Cardiol 1994;74:374–80. 527. Engel PJ, Alpert BL, Hickman JR Jr. The nature and prevalence ofthe abnormal exercise electrocardiogram in mitral valve prolapse.Am Heart J 1979;98:716 –24. 528. Butman S, Chandraratna PA, Milne N, Olson H, Lyons K,Aronow WS. Stress myocardial imaging in patients with mitralvalve prolapse: evidence of a perfusion abnormality. Cathet CardiovascDiagn 1982;8:243–52. 529. Braunberger E, Deloche A, Berrebi A, et al. Very long-term results(more than 20 years) of valve repair with Carpentier’s techniques innonrheumatic mitral valve insufficiency. Circulation 2001;104:I8–11. 530. Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA,Enriquez-Sarano M. Very long-term survival and durability ofmitral valve repair for mitral valve prolapse. Circulation 2001;104:I1–7. 531. Carabello BA. Mitral regurgitation: basic pathophysiologic principles,part 1. Mod Concepts Cardiovasc Dis 1988;57:53– 8. 532. Castello R, Fagan L Jr, Lenzen P, Pearson AC, Labovitz AJ.Comparison of transthoracic and transesophageal echocardiographyfor assessment of leftsided valvular regurgitation. Am J Cardiol1991;68:1677– 80. 533. Connolly MW, Gelbfish JS, Jacobowitz IJ, et al. Surgical results formitral regurgitation from coronary artery disease. J Thorac CardiovascSurg 1986;91:379–88. 534. Cohn LH, Couper GS, Kinchla NM, Collins JJ Jr. Decreasedoperative risk of surgical treatment of mitral regurgitation with orwithout coronary artery disease. J Am Coll Cardiol 1990;16:1575–8. 535. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, SonnenblickEH. Mechanism of reduction of mitral regurgitation withvasodilator therapy. Am J Cardiol 1979;43:773–7. 536. Chatterjee K, Parmley WW, Swan HJ, Berman G, Forrester J,Marcus HS. Beneficial effects of vasodilator agents in severe mitralregurgitation due to dysfunction of subvalvar apparatus. Circulation1973;48:684 –90. 537. Enriquez-Sarano M, Basmadjian AJ, Rossi A, Bailey KR, SewardJB, Tajik AJ. Progression of mitral regurgitation: a prospectiveDoppler echocardiographic study. J Am Coll Cardiol 1999;34:1137–44. 538. Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitralregurgitation: predictive value of preoperative echocardiographicindexes of left ventricular function and wall stress. J Am CollCardiol 1984;3:235– 42. 539. Schuler G, Peterson KL, Johnson A, et al. Temporal response of leftventricular performance to mitral valve surgery. Circulation 1979;59:1218 –31. 540. Carabello BA, Nolan SP, McGuire LB. Assessment of preoperativeleft ventricular function in patients with mitral regurgitation: valueof the end-systolic wall stress-end-systolic volume ratio. Circulation1981;64:1212–7. 541. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al.Quantitative determinants of the outcome of asymptomatic mitralregurgitation. N Engl J Med 2005;352:875– 83. 542. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waitingin asymptomatic severe mitral regurgitation. Circulation 2006;113:2238–44. 543. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact ofpreoperative symptoms on survival after surgical correction oforganic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999; 99: 400 –5. 544. Crawford MH, Souchek J, Oprian CA, et al. Determinants ofsurvival and left ventricular performance after mitral valve replacement:Department of Veterans Affairs Cooperative Study on ValvularHeart Disease. Circulation 1990;81:1173– 81. 545. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, BaileyKR, Frye RL. Valve repair improves the outcome of surgery formitral regurgitation: a multivariate analysis. Circulation 1995;91:1022–8. 546. Enriquez-Sarano M, Tribouilloy C. Quantitation of mitral regurgitation: rationale, approach, and interpretation in clinical practice.Heart 2002; 88 Suppl 4:iv1–3. 547. Simonson JS, Schiller NB. Sonospirometry: a new method fornoninvasive estimation of mean right atrial pressure based ontwo-dimensional echographic measurements of the inferior venacava during measured inspiration. J Am Coll Cardiol 1988;11:557–64. 548. Carpentier A. Cardiac valve surgery — the “French correction”. J Thorac Cardiovasc Surg 1983; 86:323–37. 549. Phillips HR, Levine FH, Carter JE, et al. Mitral valve replacementfor isolated mitral regurgitation: analysis of clinical course and latepostoperative left ventricular ejection fraction. Am J Cardiol 1981;48:647–54. 550. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, BaileyKR, Frye RL. Echocardiographic prediction of survival after surgicalcorrection of organic mitral regurgitation. Circulation 1994;90:830–7. 551. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographicprediction of left ventricular function after correction of mitralregurgitation: results and clinical implications. J Am Coll Cardiol1994;24:1536–43. 552. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome aftervalve replacement for rheumatic mitral regurgitation in the era ofchordal preservation. Circulation 1994;89:191–7. 323 324 553. Flemming MA, Oral H, Rothman ED, Briesmiester K, PetrushaJA, Starling MR. Echocardiographic markers for mitral valvesurgery to preserve left ventricular performance in mitral regurgitation.Am Heart J 2000;140:476–82. 554. Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM,Krayenbuehl HP. The relationship of afterload to ejection performancein chronic mitral regurgitation. Circulation 1987;76:59–67. 555. Gaasch WH, Zile MR. Left ventricular function after surgicalcorrection of chronic mitral regurgitation. Eur Heart J 1991;12Suppl B:48 –51. 556. Host U, Kelbaek H, Hildebrandt P, Skagen K, Aldershvile J. Effectof ramipril on mitral regurgitation secondary to mitral valve prolapse.Am J Cardiol 1997;80:655– 8. 557. Marcotte F, Honos GN, Walling AD, et al. Effect of angiotensinconvertingenzyme inhibitor therapy in mitral regurgitation withnormal left ventricular function. Can J Cardiol 1997;13:479–85. 558. Tischler MD, Rowan M, LeWinter MM. Effect of enalapriltherapy on left ventricular mass and volumes in asymptomaticchronic, severe mitral regurgitation secondary to mitral valve prolapse.Am J Cardiol 1998;82:242–5. 559. Dell’Italia LJ, Meng QC, Balcells E, et al. Compartmentalization ofangiotensin II generation in the dog heart: evidence for independentmechanisms in intravascular and interstitial spaces. J Clin Invest1997;100: 253–8. 560. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy inchronic heart failure: diastolic function and mitral regurgitationimprovement by carvedilol. Am Heart J 2000;139:596–608. 561. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricularpacing in congestive heart failure: results from the MUltisiteSTimulation In Cardiomyopathy (MUSTIC) study. J Am CollCardiol 2002;40:111– 8. 562. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effectsof cardiac resynchronization therapy on functional mitral regurgitationin advanced systolic heart failure. J Am Coll Cardiol 2003;41:765–70. 563. St John Sutton MG, Plappert T, Abraham WT, et al. Effect ofcardiac resynchronization therapy on left ventricular size and functionin chronic heart failure. Circulation 2003;107:1985–90. 564. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S.Smoke-like echo in the left atrial cavity in mitral valve disease: itsfeatures and significance. J Am Coll Cardiol 1985;6:744 –9. 565. Blackshear JL, Pearce LA, Asinger RW, et al. Mitral regurgitationassociated with reduced thromboembolic events in high-risk patientswith nonrheumatic atrial fibrillation: Stroke Prevention inAtrial Fibrillation Investigators. Am J Cardiol 1993;72:840 –3. 566. Croft CH, Lipscomb K, Mathis K, et al. Limitations of qualitativeangiographic grading in aortic or mitral regurgitation. Am J Cardiol1984;53:1593– 8. 567. Fuchs RM, Heuser RR, Yin FC, Brinker JA. Limitations ofpulmonary wedge V waves in diagnosing mitral regurgitation. Am JCardiol 1982;49:849 –54. 568. Duran CG, Pomar JL, Revuelta JM, et al. Conservative operationfor mitral insufficiency: critical analysis supported by postoperativehemodynamic studies of 72 patients. J Thorac Cardiovasc Surg1980;79:326 –37. 569. Yacoub M, Halim M, Radley-Smith R, McKay R, Nijveld A,Towers M. Surgical treatment of mitral regurgitation caused byfloppy valves: repair versus replacement. Circulation 1981;64:II210–6. 570. David TE, Uden DE, Strauss HD. The importance of the mitralapparatus in left ventricular function after correction of mitralregurgitation. Circulation 1983;68:II76–82. 571. Perier P, Deloche A, Chauvaud S, et al. Comparative evaluation ofmitral valve repair and replacement with Starr, Bjork, and porcinevalve prostheses. Circulation 1984;70:I187–92. 572. Goldman ME, Mora F, Guarino T, Fuster V, Mindich BP. Mitralvalvuloplasty is superior to valve replacement for preservation of leftventricular function: an intraoperative two-dimensional echocardiographicstudy. J Am Coll Cardiol 1987;10:568 –75. 573. Tischler MD, Cooper KA, Rowen M, LeWinter MM. Mitral valvereplacement versus mitral valve repair: a Doppler and quantitativestress echocardiographic study. Circulation 1994;89:132–7. 574. Rushmer RF. Initial phase of ventricular systole: asynchronouscontraction. Am J Physiol 1956;184:188 –94. 575. Gillinov AM, Cosgrove DM, Lytle BW, et al. Reoperation forfailure of mitral valve repair. J Thorac Cardiovasc Surg 1997;113:467–73. 576. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability ofmitral valve repair for degenerative disease. J Thorac CardiovascSurg 1998;116:734–43. 577. Gillinov AM, Cosgrove DM. Mitral valve repair for degenerativedisease. J Heart Valve Dis 2002;11 Suppl 1:S15–S20. 578. Mohty D, Enriquez-Sarano M. The long-term outcome of mitral valve repair for mitral valve prolapse. Curr Cardiol Rep 2002;4:104–10. 579. David TE, Burns RJ, Bacchus CM, Druck MN. Mitral valvereplacement for mitral regurgitation with and without preservationof chordae tendineae. J Thorac Cardiovasc Surg 1984;88:718 –25. 580. Hennein HA, Swain JA, McIntosh CL, Bonow RO, Stone CD, Clark RE. Comparative assessment of chordal preservation versuschordal resection during mitral valve replacement. J Thorac Cardiovasc Surg 1990; 99: 828 –36. 581. Rozich JD, Carabello BA, Usher BW, Kratz JM, Bell AE, Zile MR.Mitral valve replacement with and without chordal preservation inpatients with chronic mitral regurgitation: mechanisms for differencesin postoperative ejection performance. Circulation 1992;86:1718–26. 582. Horskotte D, Schulte HD, Bircks W, Strauer BE. The effect ofchordal preservation on late outcome after mitral valve replacement:a randomized study. J Heart Valve Dis 1993;2:150–8. 583. Ling LH, Enriquez-Sarano M, Seward JB, et al. Early surgery inpatients with mitral regurgitation due to flail leaflets: a long-termoutcome study. Circulation 1997;96:1819 –25. 584. Craver JM, Cohen C, Weintraub WS. Case-matched comparisonof mitral valve replacement and repair. Ann Thorac Surg 1990;49:964–9. 585. Wells FC. Conservation and surgical repair of the mitral valve. In:Wells FC, Shapiro LM, editors. Mitral Valve Disease. London,UK: Butterworths, 1996:114 –34. 586. David TE, Omran A, Armstrong S, Sun Z, Ivanov J. Long-termresults of mitral valve repair for myxomatous disease with andwithout chordal replacement with expanded polytetrafluoroethylenesutures. J Thorac Cardiovasc Surg 1998;115:1279–85. 587. Duran CM. Surgical techniques for the repair of anterior mitralleaflet prolapse. J Card Surg 1999;14:471– 81. 325 588. Alfieri O, Maisano F, De Bonis M, et al. The double-orificetechnique in mitral valve repair: a simple solution for complexproblems. J Thorac Cardiovasc Surg 2001;122:674–81. 589. Burkhart HM, Orszulak TA. Complicated mitral valve repairs.Cardiol Rev 2001;9:106 –11. 590. Dreyfus GD, Bahrami T, Alayle N, Mihealainu S, Dubois C, DeLentdecker P. Repair of anterior leaflet prolapse by papillary musclerepositioning: a new surgical option. Ann Thorac Surg 2001;71:1464–70. 591. Alfieri O, Elefteriades JA, Chapolini RJ, et al. Novel suture devicefor beatingheart mitral leaflet approximation. Ann Thorac Surg 2002;74:1488 –93. 592. Feindel CM, Tufail Z, David TE, Ivanov J, Armstrong S. Mitralvalve surgery in patients with extensive calcification of the mitralannulus. J Thorac Cardiovasc Surg 2003;126:777– 82. 593. Savage EB. Use of valve repair: analysis of contemporary UnitedStates experience reported to the Society of Thoracic SurgeonsNational Cardiac Database. Ann Thorac Surg 2003;75:820 –5. 594. Gaasch WH, John RM, Aurigemma GP. Managing asymptomatic patients with chronic mitral regurgitation. Chest 1995;108:842–7. 595. Ross J Jr. The timing of surgery for severe mitral regurgitation. N Engl J Med 1996; 335:1456–8. 596. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med 1997; 337:32– 41. 597. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-termoutcome of mitral reconstruction in cardiomyopathy. J ThoracCardiovasc Surg 1998; 115:381– 6. 598. Chen FY, Adams DH, Aranki SF, et al. Mitral valve repair incardiomyopathy. Circulation 1998;98:II124 –27. 599. Bishay ES, McCarthy PM, Cosgrove DM, et al. Mitral valvesurgery in patients with severe left ventricular dysfunction. EurJ Cardiothorac Surg 2000; 17:213–21. 600. Bolling SF. Mitral reconstruction in cardiomyopathy. J Heart ValveDis 2002;11 Suppl 1:S26 –S31. 601. Badhwar V, Bolling SF. Mitral valve surgery in the patient with leftventricular dysfunction. Semin Thorac Cardiovasc Surg 2002;14:133–6. 602. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk inpatients with mitral regurgitation and left ventricular systolic dysfunction.J Am Coll Cardiol 2005;45:381–7. 603. Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillationcomplicating the course of degenerative mitral regurgitation: determinantsand long-term outcome. J Am Coll Cardiol 2002;40:84–92. 604. Lim E, Barlow CW, Hosseinpour AR, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circulation2001;104:I59–63. 605. Eguchi K, Ohtaki E, Matsumura T, et al. Pre-operative atrialfibrillation as the key determinant of outcome of mitral valve repairfor degenerative mitral regurgitation. Eur Heart J 2005;26:1866 –72. 606. Betriu A, Chaitman BR, Almazan A. Preoperative determinants ofreturn to sinus rhythm after valve replacement. In: Cohn LH,Gallucci V, editors. Cardiac Bioprosthesis. New York, NY: 1982:184–91. 607. Chua YL, Schaff HV, Orszulak TA, Morris JJ. Outcome of mitralvalve repair in patients with preoperative atrial fibrillation: should the maze procedure 326 327 be combined with mitral valvuloplasty? J ThoracCardiovasc Surg 1994; 107:408 –15. 608. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriquez-Sarano M. Outcome of valve repair and the Cox-Maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg 1999; 118:628 –35. 609. Schaff HV, Dearani JA, Daly RC, Orszulak TA, Danielson GK. Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience.Semin Thorac Cardiovasc Surg 2000;12:30 –7. 610. Cox JL. Intraoperative options for treating atrial fibrillation associatedwith mitral valve disease. J Thorac Cardiovasc Surg 2001;122:212–5. 611. Raanani E, Albage A, David TE, Yau TM, Armstrong S. Theefficacy of the Cox-Maze procedure combined with mitral valvesurgery: a matched control study. Eur J Cardiothorac Surg 2001;19:438–42. 612. Kobayashi J, Sasako Y, Bando K, et al. Eight-year experience ofcombined valve repair for mitral regurgitation and maze procedure.J Heart Valve Dis 2002;11:165–71. 613. Abreu Filho CAC, Lisboa LA, Dallan LA. Effectiveness of themaze procedure using cooled-tip radiofrequency ablation in patientswith permanent atrial fibrillation and rheumatic mitral valve disease.Circulation 2005;112:I20–5. 614. Bando K, Kasegawa H, Okada Y, et al. Impact of preoperative andpostoperative atrial fibrillation on outcome after mitral valvuloplastyfor nonischemic mitral regurgitation. J Thorac Cardiovasc Surg2005;129:1032– 40. 615. Akins CW, Hilgenberg AD, Buckley MJ, et al. Mitral valvereconstruction versus replacement for degenerative or ischemicmitral regurgitation. Ann Thorac Surg 1994;58:668 –75. 616. Otsuji Y, Handschumacher MD, Schwammenthal E, et al. Insightsfrom three-dimensional echocardiography into the mechanism offunctional mitral regurgitation: direct in vivo demonstration ofaltered leaflet tethering geometry. Circulation 1997;96:1999–2008. 617. Otsuji Y, Gilon D, Jiang L, et al. Restricted diastolic opening of themitral leaflets in patients with left ventricular dysfunction: evidencefor increased valve tethering. J Am Coll Cardiol 1998;32:398–404. 618. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation inpatients with systolic left ventricular dysfunction: a quantitativeclinical study. Circulation 2000;102:1400–6. 619. Kumanohoso T, Otsuji Y, Yoshifuku S, et al. Mechanism of higherincidence of ischemic mitral regurgitation in patients with inferiormyocardial infarction: quantitative analysis of left ventricular andmitral valve geometry in 103 patients with prior myocardial infarction.J Thorac Cardiovasc Surg 2003;125:135– 43. 620. Kwan J, Shiota T, Agler DA, et al. Geometric differences of themitral apparatus between ischemic and dilated cardiomyopathy withsignificant mitral regurgitation: real-time three-dimensional echocardiographystudy. Circulation 2003;107:1135– 40. 621. Levine RA. Dynamic mitral regurgitation—more than meets theeye. N Engl J Med 2004;351:1681– 4. 622. Schwammenthal E, Levine RA. The non-ischaemic dynamics ofischaemic mitral regurgitation: solving the paradox. Eur Heart J2005;26:1454 –5. 623. Levine RA, Schwammenthal E. Ischemic mitral regurgitation onthe threshold of a solution: from paradoxes to unifying concepts. Circulation 2005;112:745–58. 624. Prifti E, Bonacchi M, Frati G, et al. Should mild-to-moderate andmoderate ischemic mitral regurgitation be corrected in patients withimpaired left ventricular function undergoing simultaneous coronaryrevascularization? J Card Surg 2001;16:473– 83. 625. Harris KM, Sundt TM III, Aeppli D, Sharma R, Barzilai B. Canlate survival of patients with moderate ischemic mitral regurgitationbe impacted by intervention on the valve? Ann Thorac Surg2002;74:1468 –75. 626. Lam BK, Gillinov AM, Blackstone EH, et al. Importance ofmoderate ischemic mitral regurgitation. Ann Thorac Surg 2005;79:462–70. 627. Schroder JN, Williams ML, Hata JA, et al. Impact of mitral valveregurgitation evaluated by intraoperative transesophageal echocardiographyon longterm outcomes after coronary artery bypassgrafting. Circulation 2005;112: I293–8. 628. Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance ofmitral regurgitation after acute myocardial infarction: Survival andVentricular Enlargement Investigators. Circulation 1997;96:827–33. 629. Duarte IG, Shen Y, MacDonald MJ, Jones EL, Craver JM, GuytonRA. Treatment of moderate mitral regurgitation and coronarydisease by coronary bypass alone: late results. Ann Thorac Surg1999;68:426 –30. 630. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ.Ischemic mitral regurgitation: long-term outcome and prognosticimplications with quantitative Doppler assessment. Circulation2001;103:1759–64. 631. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure anddeath after myocardial infarction in the community: the emergingrole of mitral regurgitation. Circulation 2005;111:295–301. 632. Tolis GA Jr, Korkolis DP, Kopf GS, Elefteriades JA. Revascularizationalone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitralregurgitation. Ann Thorac Surg 2002;74:1476–80. 633. Byrne JG, Aklog L, Adams DH. Assessment and management offunctional or ischaemic mitral regurgitation. Lancet 2000;355:1743–4. 634. Grossi EA, Zakow PK, Sussman M, et al. Late results of mitralvalve reconstruction in the elderly. Ann Thorac Surg 2000;70:1224–6. 635. Gangemi JJ, Tribble CG, Ross SD, McPherson JA, Kern JA, KronIL. Does the additive risk of mitral valve repair in patients withischemic cardiomyopathy prohibit surgical intervention? Ann Surg2000;231:710–4. 636. Prifti E, Bonacchi M, Frati G, Giunti G, Babatasi G, Sani G.Ischemic mitral valve regurgitation grade II-III: correction inpatients with impaired left ventricular function undergoing simultaneouscoronary revascularization. J Heart Valve Dis 2001;10:754–62. 637. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferableto replacement for ischemic mitral regurgitation? J Thorac CardiovascSurg 2001;122:1125– 41. 638. Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitral valvereconstruction and replacement: comparison of long-term survivaland complications. J Thorac Cardiovasc Surg 2001;122:1107–24. 639. Adams DH, Filsoufi F, Aklog L. Surgical treatment of the ischemicmitral valve. J Heart Valve Dis 2002;11 Suppl 1:S21–5. 328 640. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypassgrafting alone correct moderate ischemic mitral regurgitation? Circulation 2001; 104:I68 –75. 641. Gillinov AM, Faber C, Houghtaling PL, et al. Repair versusreplacement for degenerative mitral valve disease with coexistingischemic heart disease. J Thorac Cardiovasc Surg 2003;125:1350–62. 642. Campwala SZ, Bansal RC, Wang N, Razzouk A, Pai RG. Factorsaffecting regression of mitral regurgitation following isolated coronaryartery bypass surgery. Eur J Cardiothorac Surg 2005;28:104–8. 643. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shockcomplicating acute myocardial infarction— etiologies, managementand outcome: a report from the SHOCK Trial Registry. SHould weemergently revascularize Occluded Coronaries for cardiogenicshocK? J Am Coll Cardiol 2000; 36: 1063–70. 644. Tavakoli R, Weber A, Vogt P, Brunner HP, Pretre R, Turina M.Surgical management of acute mitral valve regurgitation due topost-infarction papillary muscle rupture. J Heart Valve Dis 2002;11:20 –5. 645. Edmunds LH Jr. Ischemic mitral regurgitation. In: Edmunds LHJr, editor. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill Co., 1997:657–76. 646. Cohn LH, Rizzo RJ, Adams DH, et al. The effect of pathophysiologyon the surgical treatment of ischemic mitral regurgitation:operative and late risks of repair versus replacement. Eur J Cardiothorac Surg 1995; 9:568 –74. 647. Lee EM, Porter JN, Shapiro LM, Wells FC. Mitral valve surgery inthe elderly. J Heart Valve Dis 1997;6:22–31. 648. Sahar G, Abramov D, Erez E, et al. Outcome and risk factors inoctogenarians undergoing open-heart surgery. J Heart Valve Dis1999;8:162– 6. 649. Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariableprediction of in-hospital mortality associated with aortic and mitralvalve surgery in Northern New England. Ann Thorac Surg 2004;77:1966 –77. 650. Nagendran J, Norris C, Maitland A, Koshal A, Ross DB. Is mitralvalve surgery safe in octogenarians? Eur J Cardiothorac Surg 2005;28:83–7. 651. DiGregorio V, Zehr KJ, Orszulak TA, et al. Results of mitralsurgery in octogenarians with isolated nonrheumatic mitral regurgitation. Ann Thorac Surg 2004;78:807–13. 652. Burwash IG, Thomas DD, Sadahiro M, et al. Dependence ofGorlin formula and continuity equation valve areas on transvalvularvolume flow rate in valvular aortic stenosis. Circulation 1994;89:827–35. 653. Lorell DH, Grossman W. Dynamic and isometric exercise duringcardiac catheterization. In: Baim DS, Grossman W, Cardiac Catheterization Angiography and Intervention. Baltimore, MD: Williamsand Wilkins, 1996: 281–96. 654. Sheehan FH, Mitten-Lewis S. Factors influencing accuracy in leftventricular volume determination. Am J Cardiol 1989;64:661– 4. 655. Fawzy ME, Mimish L, Sivanandam V, et al. Immediate andlong-term effect of mitral balloon valvotomy on severe pulmonaryhypertension in patients with mitral stenosis. Am Heart J 1996;131:89–93. 656. Skudicky D, Essop MR, Sareli P. Efficacy of mitral balloonvalvotomy in reducing the severity of associated tricuspid valveregurgitation. Am J Cardiol 1994;73:209–11. 657. Duran CM. Tricuspid valve surgery revisited. J Card Surg 1994;9:242–7. 658. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valverepair: durability and risk factors for failure. J Thorac CardiovascSurg 2004;127:674–5. 329 330 659. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspidregurgitation or dilatation: which should be the criteria for surgicalrepair? Ann Thorac Surg 2005;79:127–32. 660. Fukuda S, Song JM, Gillinov AM, et al. Tricuspid valve tetheringpredicts residual tricuspid regurgitation after tricuspid annuloplasty.Circulation 2005;111:975–9. 661. Gillinov AM, Blackstone EH, Cosgrove DM III, et al. Mitral valverepair with aortic valve replacement is superior to double valvereplacement. J Thorac Cardiovasc Surg 2003;125:1372–87. 662. Waller BF, Moriarty AT, Eble JN, Davey DM, Hawley DA, PlessJE. Etiology of pure tricuspid regurgitation based on anular circumferenceand leaflet area: analysis of 45 necropsy patients with clinicaland morphologic evidence of pure tricuspid regurgitation. J Am CollCardiol 1986;7:1063–74. 663. Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosisand pure tricuspid regurgitation—part III. Clin Cardiol 1995;18:225–30. 664. Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosisand pure tricuspid regurgitation—part I. Clin Cardiol 1995;18:97–102. 665. Wooley CF, Fontana ME, Kilman JW, Ryan JM. Tricuspidstenosis: atrial systolic murmur, tricuspid opening snap, and rightatrial pressure pulse. Am J Med 1985;78:375–84. 666. Naylor CD. Systolic propulsion of the eyeballs in tricuspid regurgitation. Lancet 1995;346:1706–84. 667. Hollins GW, Engeset J. Pulsatile varicose veins associated withtricuspid regurgitation. Br J Surg 1989;76:207–84. 668. Amidi M, Irwin JM, Salerni R, et al. Venous systolic thrill andmurmur in the neck: a consequence of severe tricuspid insufficiency.J Am Coll Cardiol 1986;7:942–5. 669. Rivera JM, Vandervoort PM, Vazquez de Prada JA, et al. Whichphysical factors determine tricuspid regurgitation jet area in theclinical setting? Am J Cardiol 1993;72:1305–9. 670. Yada I, Tani K, Shimono T, Shikano K, Okabe M, Kusagawa M.Preoperative evaluation and surgical treatment for tricuspid regurgitationassociated with acquired valvular heart disease: the Kay-Boyd method vs the CarpentierEdwards ring method. J CardiovascSurg (Torino) 1990;31:771–7. 671. Pellegrini A, Colombo T, Donatelli F, et al. Evaluation andtreatment of secondary tricuspid insufficiency. Eur J CardiothoracSurg 1992;6:288–96. 672. De Simone R, Lange R, Tanzeem A, Gams E, Hagl S. Adjustabletricuspid valve annuloplasty assisted by intraoperative transesophagealcolor Doppler echocardiography. Am J Cardiol 1993;71:926–31. 673. Kratz J. Evaluation and management of tricuspid valve disease.Cardiol Clin 1991;9:397–407. 674. Orbe LC, Sobrino N, Arcas R, et al. Initial outcome of percutaneousballoon valvuloplasty in rheumatic tricuspid valve stenosis. Am JCardiol 1993;71:353–4. 675. Onate A, Alcibar J, Inguanzo R, Pena N, Gochi R. Balloon dilationof tricuspid and pulmonary valves in carcinoid heart disease. TexHeart Inst J 1993;20:115–9. 676. Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspidregurgitation is a marker for adverse outcome in patients undergoingpercutaneous balloon mitral valvuloplasty. J Am Coll Cardiol1994;24:696–702. 677. Lange R, De Simone R, Bauernschmitt R, Tanzeem A, Schmidt C,Hagl S. Tricuspid valve reconstruction, a treatment option in acuteendocarditis. Eur J Cardiothorac Surg 1996;10:320–6. 678. Sutlic Z, Schmid C, Borst HG. Repair of flail anterior leaflets oftricuspid and mitral valves by cusp remodeling. Ann Thorac Surg1990;50:927–30. 679. Choi JB, Kim HK, Yoon HS, Jeong JW. Partial annular plicationfor atrioventricular valve regurgitation. Ann Thorac Surg 1995;59:891–5. 680. De Paulis R, Bobbio M, Ottino G, et al. The De Vega tricuspidannuloplasty: perioperative mortality and long term follow-up.J Cardiovasc Surg (Torino) 1990;31:512–7. 681. Minale C, Lambertz H, Nikol S, Gerich N, Messmer BJ. Selectiveannuloplasty of the tricuspid valve: two-year experience. J ThoracCardiovasc Surg 1990;99:846–51. 682. Aoyagi S, Tanaka K, Hara H, et al. Modified De Vega’s annuloplastyfor functional tricuspid regurgitation—early and late results.Kurume Med J 1992;39:23–32. 683. Holper K, Haehnel JC, Augustin N, Sebening F. Surgery fortricuspid insufficiency: long-term follow-up after De Vega annuloplasty.Thorac Cardiovasc Surg 1993;41:1–8. 684. Peltola T, Lepojarvi M, Ikaheimo M, Karkola P. De Vega’sannuloplasty for tricuspid regurgitation. Ann Chir Gynaecol 1996;85:40–3. 685. Scully HE, Armstrong CS. Tricuspid valve replacement: fifteenyears of experience with mechanical prostheses and bioprostheses.J Thorac Cardiovasc Surg 1995;109:1035–41. 686. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart diseaseassociated with fenfluramine-phentermine. N Engl J Med 1997;337:581– 8. 687. Graham DJ, Green L. Further cases of valvular heart diseaseassociated with fenfluramine-phentermine. N Engl J Med 1997;337:635– 8. 688. Langreth, R Johannes L. Diet-drug mystery grows as new researchdata emerge. Wall Street Journal: New York, NY, October 31,1997. B.1. 689. Centers for Disease Control and Prevention (CDC). Cardiacvalvulopathy associated with exposure to fenfluramine or dexfenfluramine:U.S. Department of Health and Human Services interimpublic health recommendations, November 1997. MMWR MorbidMortal Wkly Rep 1997;46:1061– 6. 690. FDA Home Page. Center for Drug Evaluation & Research.Available at: http://www.fda.gov/cder/. Accessed November 2005. 691. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugsand the risk of primary pulmonary hypertension: InternationalPrimary Pulmonary Hypertension Study Group. N Engl J Med1996;335:609 –16. 692. Mark EJ, Patalas ED, Chang HT, Evans RJ, Kessler SC. Fatalpulmonary hypertension associated with short-term use of fenfluramineand phentermine. N Engl J Med 1997;337:602– 6. 693. Dillon K, Putnam K, Avorn J. Death from irreversible pulmonaryhypertension associated with short-t fenfluramine and phentermine. JAMA 1997; 278:1320–6. 694. Thorson AH. Endocardial sclerosis and other heart lesions in thecarcinoid disease. Acta Med Scand Suppl 1958;278:99 –119. 695. Redfield MM, Nicholson WJ, Edwards WD, Tajik AJ. Valvedisease associated with ergot alkaloid use: echocardiographic andpathologic correlations. Ann Intern Med 1992;117:50 –2. 331 696. Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heartdisease: clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87:1188 –96. 697. Redfield MM. Ergot alkaloid heart disease. In: Hurst JW, NewTypes of Cardiovascular Diseases: Topics in Clinical Cardiology.New York, NY: IgakuShoin Medical, 1994;63–76. 698. Robiolio PA, Rigolin VH, Wilson JS, et al. Carcinoid heart disease:correlation of high serotonin levels with valvular abnormalitiesdetected by cardiac catheterization and echocardiography. Circulation1995;92:790 –5. 699. Wilke A, Hesse H, Hufnagel G, Maisch B. Mitral, aortic andtricuspid valvular heart disease associated with ergotamine therapyfor migraine. Eur Heart J 1997;18:701–5. 700. Rothman RB, Baumann MH, Savage JE, et al. Evidence forpossible involvement of 5-HT (2B) receptors in the cardiac valvulopathyassociated with fenfluramine and other serotonergic medications. Circulation 2000; 102: 2836–41. 701. Burger AJ, Sherman HB, Charlamb MJ, et al. Low prevalence ofvalvular heart disease in 226 phentermine-fenfluramine protocolsubjects prospectively followed for up to 30 months. J Am CollCardiol 1999;34:1153– 8. 702. Tovar EA, Landa DW, Borsari BE. Dose effect of fenfluraminephenterminein the production of valvular heart disease. AnnThorac Surg 1999; 67:1213–4. 703. Jollis JG, Landolfo CK, Kisslo J, Constantine GD, Davis KD, RyanT. Fenfluramine and phentermine and cardiovascular findings: effectof treatment duration on prevalence of valve abnormalities. Circulation 2000; 101:2071–7. 704. Lepor NE, Gross SB, Daley WL, et al. Dose and duration offenfluraminephentermine therapy impacts the risk of significantvalvular heart disease. Am J Cardiol 2000;86:107–10. 705. Burger AJ, Charlamb MJ, Singh S, Notarianni M, Blackburn GL,Sherman HB. Low risk of significant echocardiographic valvulopathyin patients treated with anorectic drugs. Int J Cardiol 2001;79:159–5. 706. Davidoff R, McTiernan A, Constantine G, et al. Echocardiographicexamination of women previously treated with fenfluramine: longtermfollow-up of a randomized, double-blind, placebo-controlledtrial. Arch Intern Med 2001; 161:1429 –36. 707. Sachdev M, Miller WC, Ryan T, Jollis JG. Effect of fenfluraminederivativediet pills on cardiac valves: a meta-analysis of observationalstudies. Am Heart J 2002;144:1065–73. 708. Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR,Jensen MD. Echocardiographic improvement over time after cessationof use of fenfluramine and phentermine. Mayo Clin Proc1999;74:1191–7. 709. Vagelos R, Jacobs M, Popp RL, Liang D. Reversal of Phen-Fenassociated valvular regurgitation documented by serial echocardiography.J Am Soc Echocardiogr 2002;15:653–7. 710. Bach DS, Rissanen AM, Mendel CM, et al. Absence of cardiacvalve dysfunction in obese patients treated with sibutramine. ObesRes 1999;7:363–9. 711. Glazer G. Long-term pharmacotherapy of obesity 2000: a review ofefficacy and safety. Arch Intern Med 2001;161:1814 –24. 712. Pritchett AM, Morrison JF, Edwards WD, Schaff HV, ConnollyHM, Espinosa RE. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002;77:1280–6. 332 333 713. Flowers CM, Racoosin JA, Lu SL, Beitz JG. The US Food andDrug Administration’s registry of patients with pergolide-associatedvalvular heart disease. Mayo Clin Proc 2003;78:730 –1. 714. Van CG, Flamez A, Cosyns B, et al. Treatment of Parkinson’sdisease with pergolide and relation to restrictive valvular heartdisease. Lancet 2004;363:1179–83. 715. Handa N, McGregor CG, Danielson GK, et al. Valvular heartoperation in patients with previous mediastinal radiation therapy.Ann Thorac Surg 2001;71:1880–4. 716. Handa N, McGregor CG, Danielson GK, et al. Coronary arterybypass grafting in patients with previous mediastinal radiationtherapy. J Thorac Cardiovasc Surg 1999;117:1136–42. 717. Hancock SL, Tucker MA, Hoppe RT. Factors affecting latemortality from heart disease after treatment of Hodgkin’s disease. JAMA 1993; 270: 1949–55. 718. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiographyin infective endocarditis: reassessment of prognostic implications ofvegetation size determined by the transthoracic and the transesophagealapproach. J Am Coll Cardiol 1989;14:631– 8. 719. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS.Infective endocarditis: an analysis based on strict case definitions.Ann Intern Med 1981;94:505–18. 720. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis ofinfective endocarditis: utilization of specific echocardiographic findings:Duke Endocarditis Service. Am J Med 1994;96:200 –9. 721. Habib G, Derumeaux G, Avierinos JF, et al. Value and limitationsof the Duke criteria for the diagnosis of infective endocarditis. J AmColl Cardiol 1999;33:2023–9. 722. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to theDuke criteria for the diagnosis of infective endocarditis. Clin InfectDis 2000;30:633– 8. 723. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis:diagnosis, antimicrobial therapy, and management of complications:a statement for healthcare professionals from the Committee onRheumatic Fever, Endocarditis, and Kawasaki Disease, Council onCardiovascular Disease in the Young, and the Councils on ClinicalCardiology, Stroke, and Cardiovascular Surgery and Anesthesia,American Heart Association: endorsed by the Infectious DiseasesSociety of America. Circulation 2005;111:e3944–434. 724. Pesanti EL, Smith IM. Infective endocarditis with negative bloodcultures: an analysis of 52 cases. Am J Med 1979;66:43–50. 725. Van Scoy RE. Culture-negative endocarditis. Mayo Clin Proc 1982;57:149 –54. 726. Nunley DL, Perlman PE. Endocarditis: changing trends in epidemiology,clinical and microbiologic spectrum. Postgrad Med 1993;93:235– 8, 241–4, 247. 727. Daniel WG, Mugge A, Martin RP, et al. Improvement in thediagnosis of abscesses associated with endocarditis by transesophagealechocardiography. N Engl J Med 1991;324:795– 800. 728. Shapiro SM, Young E, De Guzman S, et al. Transesophagealechocardiography in diagnosis of infective endocarditis. Chest1994;105:377– 82. 729. Rubenson DS, Tucker CR, Stinson EB, et al. The use of echocardiographyin diagnosing culture-negative endocarditis. Circulation1981;64:641– 6. 334 730. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditiscaused by Staphylococcus aureus in injection drug users.Ann Intern Med 1994;121:873– 6. 731. Kaye D. Treatment of infective endocarditis. Ann Intern Med 1996; 124: 606–8. 732. Francioli PB. Ceftriaxone and outpatient treatment of infectiveendocarditis. Infect Dis Clin North Am 1993;7:97–115. 733. Clarkson PM, Barratt-Boyes BG. Bacterial endocarditis followinghomograft replacement of the aortic valve. Circulation 1970;42:987–91. 734. Richardson JV, Karp RB, Kirklin JW, Dismukes WE. Treatment ofinfective endocarditis: a 10-year comparative analysis. Circulation1978;58:589 –97. 735. Rossiter SJ, Stinson EB, Oyer PE, et al. Prosthetic valve endocarditis:comparison of heterograft tissue valves and mechanical valves.J Thorac Cardiovasc Surg 1978;76:795– 803. 736. Sweeney MS, Reul GJ Jr, Cooley DA, et al. Comparison ofbioprosthetic and mechanical valve replacement for active endocarditis.J Thorac Cardiovasc Surg 1985;90:676–80. 737. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM,Buckley MJ. Prosthetic valve endocarditis: analysis of factors affectingoutcome of therapy. J Thorac Cardiovasc Surg 1986;92:776–83. 738. Rocchiccioli C, Chastre J, Lecompte Y, Gandjbakhch I, Gibert C.Prosthetic valve endocarditis: the case for prompt surgical management.J Thorac Cardiovasc Surg 1986;92:784 –9. 739. Cowgill LD, Addonizio VP, Hopeman AR, Harken AH. Apractical approach to prosthetic valve endocarditis. Ann ThoracSurg 1987;43:450 –7. 740. Arbulu A, Holmes RJ, Asfaw I. Tricuspid valvulectomy withoutreplacement: twenty years’ experience. J Thorac Cardiovasc Surg1991;102:917–22. 741. Glazier JJ, Verwilghen J, Donaldson RM, Ross DN. Treatment ofcomplicated prosthetic aortic valve endocarditis with annular abscessformation by homograft aortic root replacement. J Am Coll Cardiol1991;17:1177– 82. 742. Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, BlackstoneE. Aortic valve replacement for active infectious endocarditis in 108patients: a comparison of freehand allograft valves with mechanicalprostheses and bioprostheses. J Thorac Cardiovasc Surg 1992;103:130–9. 743. Hendren WG, Morris AS, Rosenkranz ER, et al. Mitral valve repairfor bacterial endocarditis. J Thorac Cardiovasc Surg 1992;103:124–8. 744. McGiffin DC, Galbraith AJ, McLachlan GJ, et al. Aortic valve infection: risk factors for death and recurrent endocarditis afteraortic valve replacement. J Thorac Cardiovasc Surg 1992;104:511–20. 745. David TE, Armstrong S, Sun Z, Daniel L. Late results of mitralvalve repair for mitral regurgitation due to degenerative disease. AnnThorac Surg 1993;56:7–12. 746. Sett SS, Hudon MP, Jamieson WR, Chow AW. Prosthetic valveendocarditis: experience with porcine bioprostheses. J Thorac CardiovascSurg 1993;105:428 –34. 747. Aranki SF, Santini F, Adams DH, et al. Aortic valve endocarditis:determinants of early survival and late morbidity. Circulation1994;90:II175– 82. 748. Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH.Evaluation of unstented aortic homografts for the treatment ofprosthetic aortic valve endocarditis. Circulation 1994;90:II198 –204. 749. Watanabe G, Haverich A, Speier R, Dresler C, Borst HG. Surgicaltreatment of active infective endocarditis with paravalvular involvement.J Thorac Cardiovasc Surg 1994;107:171–7. 750. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis:superiority of surgical valve replacement versus medical therapy only.Ann Thorac Surg 1994;58:1073–7. 751. Acar J, Michel PL, Varenne O, Michaud P, Rafik T. Surgicaltreatment of infective endocarditis. Eur Heart J 1995;16 SupplB:94–8. 752. Cormier B, Vahanian A. Echocardiography and indications forsurgery. Eur Heart J 1995;16 Suppl B:68 –71. 753. David TE. The surgical treatment of patients with prosthetic valveendocarditis. Semin Thorac Cardiovasc Surg 1995;7:47–53. 754. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T.Surgical management of infective endocarditis associated withcerebral complications: multi-center retrospective study in Japan.J Thorac Cardiovasc Surg 1995;110:1745–55. 755. Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J 1995;16Suppl B:84 –9. 756. Acar C, Tolan M, Berrebi A, et al. Homograft replacement of themitral valve: graft selection, technique of implantation, and results inforty-three patients. J Thorac Cardiovasc Surg 1996;111:367–78. 757. Lytle BW, Priest BP, Taylor PC, et al. Surgical treatment ofprosthetic valve endocarditis. J Thorac Cardiovasc Surg 1996;111:198–207. 758. Delahaye JP, Poncet P, Malquarti V, Beaune J, Gare JP, Mann JM.Cerebrovascular accidents in infective endocarditis: role of anticoagulation.Eur Heart J 1990;11:1074–8. 759. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, QuagliarelloVJ. Complicated left-sided native valve endocarditis in adults: riskclassification for mortality. JAMA 2003;289:1933– 40. 760. Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC, SchaffHV. The advantage of repair of mitral valve in acute endocarditis.J Heart Valve Dis 2002;11:91–7. 761. Iung B, Rousseau-Paziaud J, Cormier B, et al. Contemporary resultsof mitral valve repair for infective endocarditis. J Am Coll Cardiol2004;43:386 –92. 762. Zegdi R, Debieche M, Latremouille C, et al. Long-term results ofmitral valve repair in active endocarditis. Circulation 2005;111:2532–6. 763. Elkayam U. Pregnancy and cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, Braunwald’s Heart Disease: ATextbook of Cardiovascular Medicine. 7th ed. Philadelphia, PA:Elsevier, 2005:1965. 764. De Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhancedthrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95– 00. 765. Immer FF, Bansi AG, Immer-Bansi AS, et al. Aortic dissection inpregnancy: analysis of risk factors and outcome. Ann Thorac Surg2003;76:309 –14. 766. Bryant-Greenwood GD, Schwabe C. Human relaxins: chemistryand biology. Endocr Rev 1994;15:5–26. 767. Marcus FI, Ewy GA, O’Rourke RA, Walsh B, Bleich AC. Theeffect of pregnancy on the murmurs of mitral and aortic regurgitation.Circulation 1970;41:795– 805. 768. Campos O, Andrade JL, Bocanegra J, et al. Physiologic multivalvularregurgitation during pregnancy: a longitudinal Doppler echocardiographicstudy. Int J Cardiol 1993;40:265–72. 335 769. Reimold SC, Rutherford JD. Clinical practice: valvular heart diseasein pregnancy. N Engl J Med 2003;349:52–9. 770. Elkayam U, Bitar F. Valvular heart disease and pregnancy, part I:native valves. J Am Coll Cardiol 2005;46:223–30. 771. Elkayam U, Bitar F. Valvular heart disease and pregnancy, part II:prosthetic valves. J Am Coll Cardiol 2005;46:403–10. 772. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter studyof pregnancy outcomes in women with heart disease. Circulation 2001;104:515–21. 773. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiacoutcomes are more common in pregnant women with cardiacdisease. Circulation 2002;105:2179–84. 774. Rahimtoola SH, Durairaj A, Mehra A, Nuno I. Current evaluationand management of patients with mitral stenosis. Circulation2002;106:1183– 8. 775. Palacios IF, Block PC, Wilkins GT, Rediker DE, Daggett WM.Percutaneous mitral balloon valvotomy during pregnancy in apatient with severe mitral stenosis. Cathet Cardiovasc Diagn 1988;15:109 –11. 776. Safian RD, Berman AD, Sachs B, et al. Percutaneous balloon mitralvalvuloplasty in a pregnant woman with mitral stenosis. Cathet Cardiovasc Diagn 1988;15:103– 8. 777. Esteves CA, Ramos AI, Braga SL, Harrison JK, Sousa JE. Effectivenessof percutaneous balloon mitral valvotomy during pregnancy.Am J Cardiol 1991;68:930–4. 778. Ben Farhat M, Maatouk F, Betbout F, et al. Percutaneous balloonmitral valvuloplasty in eight pregnant women with severe mitralstenosis. Eur Heart J 1992;13:1658–64. 779. Chow WH, Chow TC, Wat MS, Cheung KL. Percutaneousballoon mitral valvotomy in pregnancy using the Inoue ballooncatheter. Cardiology 1992;81:182–5. 780. Kultursay H, Turkoglu C, Akin M, Payzin S, Soydas C, Akilli A.Mitral balloon valvuloplasty with transesophageal echocardiographywithout using fluoroscopy. Cathet Cardiovasc Diagn 1992;27:317–21. 781. Ribeiro PA, Fawzy ME, Awad M, Dunn B, Duran CG. Balloonvalvotomy for pregnant patients with severe pliable mitral stenosisusing the Inoue technique with total abdominal and pelvic shielding. Am Heart J 1992; 124:1558–62. 782. Ruzyllo W, Dabrowski M, Woroszylska M, Rydlewska-Sadowska W. Percutaneous mitral commissurotomy with the Inoue balloonfor severe mitral stenosis during pregnancy. J Heart Valve Dis1992;1:209 –12. 783. Patel JJ, Mitha AS, Hassen F, et al. Percutaneous balloon mitralvalvotomy in pregnant patients with tight pliable mitral stenosis.Am Heart J 1993;125:1106 –9. 784. Iung B, Cormier B, Elias J, et al. Usefulness of percutaneous ballooncommissurotomy for mitral stenosis during pregnancy. Am J Cardiol 1994;73:398–400. 785. Pavankumar P, Venugopal P, Kaul U, et al. Closed mitral valvotomyduring pregnancy: a 20–year experience. Scand J Thorac CardiovascSurg 1988;22:11–5. 786. Lao TT, Adelman AG, Sermer M, Colman JM. Balloon valvuloplastyfor congenital aortic stenosis in pregnancy. Br J ObstetGynaecol 1993;100:1141–2. 787. Banning AP, Pearson JF, Hall RJ. Role of balloon dilatation of theaortic valve in pregnant patients with severe aortic stenosis. BrHeart J 1993;70:544 –5. 788. Sheikh F, Rangwala S, DeSimone C, Smith HS, O’Leary AM.Management of the parturient with severe aortic incompetence.J Cardiothorac Vasc Anesth 1995;9:575–7. 789. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. Aprospective longitudinal evaluation of pregnancy in the Marfansyndrome. Am J Obstet Gynecol 1995;173:1599–606. 790. Elkayam U, Ostrzega E, Shotan A, Mehra A. Cardiovascularproblems in pregnant women with the Marfan syndrome. AnnIntern Med 1995; 123: 117–22. 791. Rossouw GJ, Knott-Craig CJ, Barnard PM, Macgregor LA, VanZyl WP. Intracardiac operation in seven pregnant women. AnnThorac Surg 1993;55:1172– 4. 792. Goldstein I, Jakobi P, Gutterman E, Milo S. Umbilical artery flowvelocity during maternal cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 1116–8. 793. Sullivan HJ. Valvular heart surgery during pregnancy. Surg Clin North Am 1995;75:59 –75. 794. Expert consensus document on management of cardiovasculardiseases during pregnancy. Eur Heart J 2003;24:761– 81. 795. Rahimtoola SH. Choice of prosthetic heart valve for adult patients.J Am Coll Cardiol 2003;41:893–904. 796. Wahlers T, Laas J, Alken A, Borst HG. Repair of acute type Aaortic dissection after cesarean section in the thirty-ninth week ofpregnancy. J Thorac Cardiovasc Surg 1994;107:314 –5. 797. Jayaram A, Carp HM, Davis L, Jacobson SL. Pregnancy complicatedby aortic dissection: caesarean delivery during extraduralanaesthesia. Br J Anaesth 1995;75:358–60. 798. Jamieson WR, Miller DC, Akins CW, et al. Pregnancy andbioprostheses: influence on structural valve deterioration. AnnThorac Surg 1995;60:S282– 6. 799. Dore A, Somerville J. Pregnancy in patients with pulmonaryautograft valve replacement. Eur Heart J 1997;18:1659–62. 800. Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA, ZajariasA, Salazar E. Risks of anticoagulant therapy in pregnant womenwith artificial heart valves. N Engl J Med 1986;315:1390 –3. 801. Sbarouni E, Oakley CM. Outcome of pregnancy in women withvalve prostheses. Br Heart J 1994;71:196 –201. 802. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy.Circulation 2003;107:1240–6. 803. Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome ofexposure to anticoagulants during pregnancy. Am J Med Genet1993;45:17–21. 804. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association / American College of Cardiology Foundation guide to warfarintherapy. J Am Coll Cardiol 2003;41:1633–52. 805. Hirsh J, Fuster V. Guide to anticoagulant therapy, part 2: oralanticoagulants. American Heart Association. Circulation 1994;89:1469–80. 806. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusteddoses of subcutaneous heparin to prevent thromboembolic phenomenain pregnant patients with mechanical cardiac valve prostheses.J Am Coll Cardiol 1996;27:1698 –703. 807. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1995;108:305S–11S. 337 808. Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirinwith placebo in patients treated with warfarin after heart-valvereplacement. N Engl J Med 1993;329:524 –9. 809. Oakley CM. Pregnancy and prosthetic heart valves. Lancet 1994;344:1643– 4. 810. Elkayam UR. Anticoagulation in pregnant women with prostheticheart valves: a double jeopardy. J Am Coll Cardiol 1996;27:1704–6. 811. Ginsberg JS, Chan WS, Bates SM, Kaatz S. Anticoagulation ofpregnant women with mechanical heart valves. Arch Intern Med2003;163:694–8. 812. Topol EJ. Anticoagulation with prosthetic cardiac valves. Arch Intern Med 2003; 163:2251–2. 813. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnantwomen with mechanical heart valves: a systematic review of theliterature. Arch Intern Med 2000;160:191– 6. 814. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithromboticagents during pregnancy: the Seventh ACCP Conference on Antithromboticand Thrombolytic Therapy. Chest 2004;126:627S– 44S. 815. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapyin valvular heart disease—native and prosthetic: the Seventh ACCPConference on Antithrombotic and Thrombolytic Therapy. Chest2004;126:457S– 82S. 816. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: thechanging profile of congenital heart disease in adult life. J Am CollCardiol 2001;37:1170 –5. 817. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmentalmodulation of myocardial mechanics: age- and growth-relatedalterations in afterload and contractility. J Am Coll Cardiol 1992;19:619 –29. 818. Wagner HR, Ellison RC, Keane JF, Humphries OJ, Nadas AS.Clinical course in aortic stenosis. Circulation 1977;56:I47–56. 819. Keane JF, Driscoll DJ, Gersony WM, et al. Second natural historystudy of congenital heart defects: results of treatment of patientswith aortic valvar stenosis. Circulation 1993;87:I16 –27. 820. McCrindle BW. Independent predictors of immediate results ofpercutaneous balloon aortic valvotomy in children: Valvuloplastyand Angioplasty of Congenital Anomalies (VACA) Registry Investigators.Am J Cardiol 1996;77:286 –93. 821. Moore P, Egito E, Mowrey H, Perry SB, Lock JE, Keane JF.Midterm results of balloon dilation of congenital aortic stenosis:predictors of success. J Am Coll Cardiol 1996;27:1257– 63. 822. Ross DN. Replacement of aortic and mitral valves with a pulmonaryautograft. Lancet 1967;2:956–8. 823. Takkenberg JJ, Dossche KM, Hazekamp MG, et al. Report of the Dutch experience with the Ross procedure in 343 patients. EurJ Cardiothorac Surg 2002;22:70 –7. 824. Paparella D, David TE, Armstrong S, Ivanov J. Mid-term results ofthe Ross procedure. J Card Surg 2001;16:338–43. 825. Elkins RC. The Ross operation: a 12–year experience. Ann Thorac Surg 1999;68:S14–8. 826. Bacha EA, Hijazi ZM, Cao QL, et al. New therapeutic avenues with hybrid pediatric cardiac surgery. Heart Surg Forum 2004;7:33–40. 827. Casselman FP, Gillinov AM, Akhrass R, Kasirajan V, BlackstoneEH, Cosgrove DM. Intermediate-term durability of bicuspid aorticvalve repair for prolapsing leaflet. Eur J Cardiothorac Surg 1999;15:302– 8. 338 339 828. Ruckman RN, Van Praagh R. Anatomic types of congenital mitralstenosis: report of 49 autopsy cases with consideration of diagnosisand surgical implications. Am J Cardiol 1978;42:592– 601. 829. Moore P, Adatia I, Spevak PJ, et al. Severe congenital mitralstenosis in infants. Circulation 1994;89:2099 –106. 830. Attie F, Rosas M, Rijlaarsdam M, et al. The adult patient with Ebstein anomaly: outcome in 72 unoperated patients. Medicine (Baltimore) 2000; 79: 27–36. 831. Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RK,Deanfield JE. Outcome in neonates with Ebstein’s anomaly. J AmColl Cardiol 1992;19:1041– 6. 832. Celermajer DS, Bull C, Till JA, et al. Ebstein’s anomaly: presentationand outcome from fetus to adult. J Am Coll Cardiol 1994;23:170–6. 833. Discigil B, Dearani JA, Puga FJ, et al. Late pulmonary valvereplacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001; 121: 344–51. 834. Kiziltan HT, Theodoro DA, Warnes CA, O’Leary PW, AndersonBJ, Danielson GK. Late results of bioprosthetic tricuspid valvereplacement in Ebstein’s anomaly. Ann Thorac Surg 1998;66:1539–45. 835. Koretzky ED, Moller JH, Korns ME, Schwartz CJ, Edwards JE.Congenital pulmonary stenosis resulting from dysplasia of valve.Circulation 1969;40:43–53. 836. Nadas AS, Ellison RC, Weidman WH. Report from the JointStudy on the Natural History of Congenital Heart Defects. Circulation 1977;56 Suppl I: I1– 87. 837. O’Fallon WM, Weidman WH. Long-term follow-up of congenitalaortic stenosis, pulmonary stenosis, and ventricular septal defect:report from the Second Joint Study on the Natural History of Congenital Heart Defects (NHS-2). Circulation 1993;87 SupplI:I1–126. 838. Brock RC. The surgical treatment of pulmonic stenosis. Br Heart J1961;23:337–3. 839. Jonas RA, Castaneda AR, Norwood WI, Freed MD. Pulmonaryvalvotomy under normothermic caval inflow occlusion. Aust N ZJ Surg 1985;55:39–44. 840. Kan JS, White RI Jr, Mitchell SE, Gardner TJ. Percutaneousballoon valvuloplasty: a new method for treating congenitalpulmonary-valve stenosis. N Engl J Med 1982;307:540 –2. 841. Stanger P, Cassidy SC, Girod DA, Kan JS, Lababidi Z, Shapiro SR.Balloon pulmonary valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol1990;65:775– 83. 842. Kaul UA, Singh B, Tyagi S, Bhargava M, Arora R, Khalilullah M.Long-term results after balloon pulmonary valvuloplasty in adults.Am Heart J 1993;126:1152–5. 843. Chen CR, Cheng TO, Huang T, et al. Percutaneous balloonvalvuloplasty for pulmonic stenosis in adolescents and adults.N Engl J Med 1996;335:21–5. 844. McCrindle BW. Independent predictors of long-term results afterballoon pulmonary valvuloplasty: Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. Circulation1994;89:1751–9. 845. Driscoll D, Allen HD, Atkins DL, et al. Guidelines for evaluationand management of common congenital cardiac problems in infants, children, and adolescents: a statement for healthcare professionals from the Committee 340 on Congenital Cardiac Defects of the Councilon Cardiovascular Disease in the Young, American Heart Association.Circulation 1994;90:2180–8. 846. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome inpatients undergoing surgical repair of tetralogy of Fallot. N EnglJ Med 1993;329:593–9. 847. Gatzoulis MA, Clark AL, Cullen S, Newman CG, Redington AN.Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. Circulation 1995;91:1775– 81. 848. Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valvereplacement on arrhythmia propensity late after repair of tetralogy ofFallot. Circulation 2001;103:2489 –94. 849. Hazekamp MG, Kurvers MM, Schoof PH, et al. Pulmonary valveinsertion late after repair of Fallot’s tetralogy. Eur J CardiothoracSurg 2001;19:667–70. 850. Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of Fallot.Circulation 2002;106:1703–7. 851. Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair oftetralogy of Fallot: are we operating too late? J Am Coll Cardiol 2000;36:1670 –5. 852. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH.Long-term performance of heart valve prostheses. Curr ProblCardiol 2000;25:73–54. 853. Edmunds LH Jr, Clark RE, Cohn LH, Miller C, Weisel RD.Guidelines for reporting morbidity and mortality after cardiacvalvular operations. Ann Thorac Surg 1988;46:257–9. 854. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations: the American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996; 62:932–5. 855. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations: Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of the American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708 –11. 856. Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation 1978;58:20–4. 857. Rahimtoola SH. Lessons learned about the determinants of theresults of valve surgery. Circulation 1988;78:1503–7. 858. Grunkemeier GL, Starr A, Rahimtoola SH. Clinical performance of prosthetic heart valves. In: Schlant RA, Alexander RW, Hurst’s The Heart. New York, NY: McGraw-Hill, 1998;78:1851– 66. 859. Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51– 63. 860. Rahimtoola SH. Some unexpected lessons from large multicenterrandomized clinical trials. Circulation 1985;72:449 –5. 861. Grunkemeier GL, Starr A. Alternatives to randomization in surgicalstudies. J Heart Valve Dis 1992;1:142–51. 862. Bohm JO, Botha CA, Hemmer W, et al. Hemodynamic performance following the Ross operation: comparison of two differenttechniques. J Heart Valve Dis 2004;13:174–80. 341 863. Cosgrove DM, Lytle BW, Gill CC, et al. In vivo hemodynamiccomparison of porcine and pericardial valves. J Thorac CardiovascSurg 1985;89:358–68. 864. Frater RW, Salomon NW, Rainer WG, Cosgrove DM III, WickhamE. The Carpentier-Edwards pericardial aortic valve: intermediate results. Ann Thorac Surg 1992;53:764 –71. 865. Pelletier LC, Leclerc Y, Bonan R, Crepeau J, Dyrda I. Aortic valvereplacement with the Carpentier-Edwards pericardial bioprosthesis:clinical and hemodynamic results. J Card Surg 1988;3:405–12. 866. Walther T, Lehmann S, Falk V, et al. Prospectively randomizedevaluation of stented xenograft hemodynamic function in the aorticposition. Circulation 2004;110:II74–8. 867. Jamieson WR, Rosado LJ, Munro AI, et al. Carpentier-Edwardsstandard porcine bioprosthesis: primary tissue failure (structuralvalve deterioration) by age groups. Ann Thorac Surg 1988;46:155–62. 868. Cohn LH, Collins JJ Jr, DiSesa VJ, et al. Fifteen-year experiencewith 1678 Hancock porcine bioprosthetic heart valve replacements.Ann Surg 1989;210:435– 42. 869. Jones EL, Weintraub WS, Craver JM, et al. Ten-year experiencewith the porcine bioprosthetic valve: interrelationship of valvesurvival and patient survival in 1,050 valve replacements. AnnThorac Surg 1990;49:370–83. 870. Jamieson WR, Tyers GF, Janusz MT, et al. Age as a determinantfor selection of porcine bioprostheses for cardiac valve replacement:experience with Carpentier-Edwards standard bioprosthesis. CanJ Cardiol 1991;7:181– 8. 871. Pansini S, Ottino G, Caimmi F, Del Ponte S, Morea M. Riskfactors of primary tissue failure within the 11th postoperative year in217 patients with porcine bioprostheses. J Card Surg 1991;6:644–8. 872. Burdon TA, Miller DC, Oyer PE, et al. Durability of porcine valvesat fifteen years in a representative North American patient population.J Thorac Cardiovasc Surg 1992;103:238 –51. 873. Burr LH, Jamieson WR, Munro AI, et al. Structural valve deteriorationin elderly patient populations with the Carpentier-Edwardsstandard and supraannular porcine bioprostheses: a comparativestudy. J Heart Valve Dis 1992;1:87–91. 874. Pelletier LC, Carrier M, Leclerc Y, Dyrda I, Gosselin G. Influenceof age on late results of valve replacement with porcine bioprostheses.J Cardiovasc Surg (Torino) 1992;33:526 –33. 875. Cosgrove DM, Lytle BW, Taylor PC, et al. The Carpentier-Edwards pericardial aortic valve: ten-year results. J Thorac CardiovascSurg 1995;110:651– 62. 876. Pelletier LC, Carrier M, Leclerc Y, Dyrda I. The Carpentier-Edwards pericardial bioprosthesis: clinical experience with 600patients. Ann Thorac Surg 1995;60:S297–302. 877. Cohn LH, Collins JJ Jr, Rizzo RJ, Adams DH, Couper GS, ArankiSF. Twentyyear follow-up of the Hancock modified orifice porcineaortic valve. Ann Thorac Surg 1998;66:S30–4. 878. Le Tourneau T, Savoye C, McFadden EP, et al. Mid-termcomparative followup after aortic valve replacement withCarpentier-Edwards and Pericarbon pericardial prostheses. Circulation1999;100:II11– 6. 879. Jamieson WR, Lemieux MD, Sullivan JA, Munro IA, Metras J,Cartier PC. Medtronic Intact porcine bioprosthesis experience totwelve years. Ann Thorac Surg 2001;71:S278–81. 880. Banbury MK, Cosgrove DM III, Thomas JD, et al. Hemodynamicstability during 17 years of the Carpentier-Edwards aortic pericardialbioprosthesis. Ann Thorac Surg 2002;73:1460 –5. 881. Westaby S, Jin XY, Katsumata T, Arifi A, Braidley P. Valvereplacement with a stentless bioprosthesis: versatility of the porcineaortic root. J Thorac Cardiovasc Surg 1998;116:477– 4. 882. Hvass U, Palatianos GM, Frassani R, Puricelli C, O’Brien M.Multicenter study of stentless valve replacement in the small aorticroot. J Thorac Cardiovasc Surg 1999;117:267–72. 883. Yun KL, Sintek CF, Fletcher AD, et al. Aortic valve replacementwith the freestyle stentless bioprosthesis: five-year experience. Circulation 1999; 100:II17–23. 884. Dellgren G, Feindel CM, Bos J, Ivanov J, David TE. Aortic valvereplacement with the Toronto SPV: long-term clinical and hemodynamicresults. Eur J Cardiothorac Surg 2002;21:698 –702. 885. Collinson J, Henein M, Flather M, Pepper JR, Gibson DG. Valvereplacement for aortic stenosis in patients with poor left ventricularfunction: comparison of early changes with stented and stentlessvalves. Circulation 1999;100:II1–5. 886. Walther T, Falk V, Langebartels G, et al. Prospectively randomizedevaluation of stentless versus conventional biological aortic valves:impact on early regression of left ventricular hypertrophy. Circulation1999;100:II6 –10. 887. Williams RJ, Muir DF, Pathi V, MacArthur K, Berg GA. Randomizedcontrolled trial of stented and stentless aortic bioprotheses:hemodynamic performance at 3 years. Semin Thorac CardiovascSurg 1999;11:93–7. 888. Santini F, Bertolini P, Montalbano G, et al. Hancock versusstentless bioprosthesis for aortic valve replacement in patients older than 75 years. Ann Thorac Surg 1998;66:S99 –103. 889. Cohen G, Christakis GT, Joyner CD, et al. Are stentless valves hemodynamically superior to stented valves? A prospective randomizedtrial. Ann Thorac Surg 2002;73:767–75. 890. Westaby S, Horton M, Jin XY, et al. Survival advantage of stentlessaortic bioprostheses. Ann Thorac Surg 2000;70:785–90. 891. Bach DS, Goldman B, Verrier E, et al. Eight-year hemodynamicfollow-up after aortic valve replacement with the Toronto SPVstentless aortic valve. Semin Thorac Cardiovasc Surg 2001;13:173–9. 892. Lund O, Chandrasekaran V, Grocott-Mason R, et al. Primaryaortic valve replacement with allografts over twenty-five years:valve-related and procedure-related determinants of outcome.J Thorac Cardiovasc Surg 1999; 117:77–90. 893. Dossche KM, Defauw JJ, Ernst SM, Craenen TW, De Jongh BM,de la Riviere AB. Allograft aortic root replacement in prostheticaortic valve endocarditis: a review of 32 patients. Ann Thorac Surg1997;63:1644 –9. 894. Dearani JA, Orszulak TA, Schaff HV, Daly RC, Anderson BJ,Danielson GK. Results of allograft aortic valve replacement forcomplex endocarditis. J Thorac Cardiovasc Surg 1997;113:285–91. 895. Lytle BW, Sabik JF, Blackstone EH, Svensson LG, Pettersson GB,Cosgrove DM III. Reoperative cryopreserved root and ascendingaorta replacement for acute aortic prosthetic valve endocarditis. AnnThorac Surg 2002;74:S1754 –7. 896. Sabik JF. Aortic root replacement with cryopreserved allograft forprosthetic valve endocarditis. Ann Thorac Surg 2002;74:650 –9. 342 343 897. D’Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z.Long-term results of operation for paravalvular abscess. Ann ThoracSurg 1996;62:48 –53. 898. D’Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z.Long-term results of surgery for active infective endocarditis. EurJ Cardiothorac Surg 1997;11:46 –52. 899. Alexiou C, Langley SM, Stafford H, Lowes JA, Livesey SA, MonroJL. Surgery for active culture-positive endocarditis: determinants ofearly and late outcome. Ann Thorac Surg 2000;69:1448 –54. 900. Leyh RG, Knobloch K, Hagl C, et al. Replacement of the aorticroot for acute prosthetic valve endocarditis: prosthetic compositeversus aortic allograft root replacement. J Thorac Cardiovasc Surg2004;127:1416 –20. 901. Melina G, Mitchell A, Amrani M, Khaghani A, Yacoub MH.Transvalvular velocities after full aortic root replacement: resultsfrom a prospective randomized trial between the homograft and theMedtronic Freestyle bioprosthesis. J Heart Valve Dis 2002;11:54–8. 902. Ali A, Lim E, Halstead J, et al. Porcine or human stentless valves foraortic valve replacement? Results of a 10-year comparative study.J Heart Valve Dis 2003;12:430 –5. 903. Willems TP, Takkenberg JJ, Steyerberg EW, et al. Human tissuevalves in aortic position: determinants of reoperation and valveregurgitation. Circulation 2001;103:1515–21. 904. Raja SG, Pozzi M. Ross operation in children and young adults: theAlder Hey case series. BMC Cardiovasc Disord 2004;4:3–21. 905. Carr-White GS, Glennan S, Edwards S, et al. Pulmonary autograftversus aortic homograft for rereplacement of the aortic valve: resultsfrom a subset of a prospective randomized trial. Circulation 1999;100 Suppl II:II103– 6. 906. Aklog L, Carr-White GS, Birks EJ, Yacoub MH. Pulmonaryautograft versus aortic homograft for aortic valve replacement:interim results from a prospective randomized trial. J Heart ValveDis 2000;9:176–88. 907. Laforest I, Dumesnil JG, Briand M, Cartier PC, Pibarot P.Hemodynamic performance at rest and during exercise after aorticvalve replacement: comparison of pulmonary autografts versus aortichomografts. Circulation 2002;106 Suppl I:I57–I62. 908. Davierwala PM, David TE, Armstrong S, Ivanov J. Aortic valverepair versus replacement in bicuspid aortic valve disease. J HeartValve Dis 2003;12:679–86. 909. Minakata K, Schaff HV, Zehr KJ, et al. Is repair of aortic valveregurgitation a safe alternative to valve replacement? J ThoracCardiovasc Surg 2004;127:645–53. 910. Yacoub MH, Gehle P, Chandrasekaran V, Birks EJ, Child A,Radley-Smith R. Late results of a valve-preserving operation inpatients with aneurysms of the ascending aorta and root. J ThoracCardiovasc Surg 1998;115:1080 –90. 911. Leyh RG, Schmidtke C, Sievers HH, Yacoub MH. Opening andclosing characteristics of the aortic valve after different types of valve-preserving surgery. Circulation 1999;100:2153– 60. 912. David TE, Armstrong S, Ivanov J, Feindel CM, Omran A, Webb G. Results of aortic valve-sparing operations. J Thorac CardiovascSurg 2001; 122:39–46. 913. David TE. Aortic valve sparing operations. Ann Thorac Surg2002;73: 1029 –30. 914. David TE, Ivanov J, Armstrong S, Feindel CM, Webb GD. Aorticvalve-sparing operations in patients with aneurysms of the aorticroot or ascending aorta. Ann Thorac Surg 2002;74:S1758–61. 915. Burkhart HM, Zehr KJ, Schaff HV, Daly RC, Dearani JA,Orszulak TA. Valvepreserving aortic root reconstruction: a comparison of techniques. J Heart Valve Dis 2003;12:62–7. 916. Crestanello JA, Zehr KJ, Daly RC, Orszulak TA, Schaff HV. Isthere a role for the left ventricle apical-aortic conduit for acquiredaortic stenosis? J Heart Valve Dis 2004;13:57– 62. 917. Taylor KM. The Edinburgh heart valve study. Heart 2003;89:697–8. 918. Hwang MH, Burchfiel CM, Sethi GK, et al. Comparison of thecauses of late death following aortic and mitral valve replacement.VA Co-operative Study on Valvular Heart Disease. J Heart Valve Dis 1994;3:17–24. 919. Lytle BW, Cosgrove DM, Taylor PC, et al. Primary isolated aorticvalve replacement: early and late results. J Thorac Cardiovasc Surg 1989;97:675–94. 920. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysispatients in the United States with prosthetic heart valves: should theACC/AHA practice guidelines on valve selection be modified.Circulation 2002;105:1336–41. 921. Halstead JC, Tsui SS. Randomized trial of stentless versus stentedbioprostheses for aortic valve replacement. Ann Thorac Surg 2003;76:1338–9. 922. Marchand MA, Aupart MR, Norton R, et al. Fifteen-year experiencewith the mitral Carpentier-Edwards PERIMOUNT pericardialbioprosthesis. Ann Thorac Surg 2001;71:S236 –9. 923. Doenst T, Borger MA, David TE. Long-term results of bioprostheticmitral valve replacement: the pericardial perspective. J Cardiovasc Surg 2004; 45: 449–54. 924. Stewart WJ, Currie PJ, Salcedo EE, et al. Intraoperative Dopplercolor flow mapping for decision-making in valve repair for mitralregurgitation: technique and results in 100 patients. Circulation 1990;81:556–66. 925. Sheikh KH, Bengtson JR, Rankin JS, de Bruijn NP, Kisslo J.Intraoperative transesophageal Doppler color flow imaging used toguide patient selection and operative treatment of ischemic mitralregurgitation. Circulation 1991;84:594–604. 926. Click RL, Abel MD, Schaff HV. Intraoperative transesophagealechocardiography: 5–year prospective review of impact on surgicalmanagement. Mayo Clin Proc 2000;75:241–7. 927. Nowrangi SK, Connolly HM, Freeman WK, Click RL. Impact ofintraoperative transesophageal echocardiography among patientsundergoing aortic valve replacement for aortic stenosis. J Am Soc Echocardiogr 2001;14:863– 6. 928. Kallmeyer IJ, Collard CD, Fox JA, Body SC, Shernan SK. Thesafety of intraoperative transesophageal echocardiography: a caseseries of 7200 cardiac surgical patients. Anesth Analg 2001;92:1126–30. 929. Quinones MA, Douglas PS, Foster E, et al. ACC/AHA clinicalcompetence statement on echocardiography: a report of the AmericanCollege of Cardiology/American Heart Association/AmericanCollege of PhysiciansAmerican Society of Internal Medicine TaskForce on Clinical Competence. J Am Coll Cardiol 2003;41:687–708. 930. Eltzschig HK, Kallmeyer IJ, Mihaljevic T, Alapati S, Shernan SK.A practical approach to a comprehensive epicardial and epiaorticechocardiographic examination. J Cardiothorac Vasc Anesth 2003;17:422–9. 344 345 931. Meloni L, Aru G, Abbruzzese PA, et al. Regurgitant flow of mitralvalve prostheses: an intraoperative transesophageal echocardiographicstudy. J Am Soc Echocardiogr 1994;7:36–46. 932. Bach DS, Deeb GM, Bolling SF. Accuracy of intraoperative transesophageal echocardiography for estimating the severity offunctional mitral regurgitation. Am J Cardiol 1995;76:508 –12. 933. Grewal KS, Malkowski MJ, Piracha AR, et al. Effect of generalanesthesia on the severity of mitral regurgitation by transesophagealechocardiography. Am J Cardiol 2000;85:199 –203. 934. Omran AS, Woo A, David TE, Feindel CM, Rakowski H, Siu SC.Intraoperative transesophageal echocardiography accurately predictsmitral valve anatomy and suitability for repair. J Am Soc Echocardiogr2002;15:950 –7. 935. McAnulty JH, Rahimtoola SH. Antithrombotic therapy in valvularheart disease. In: Schlant R, Alexander RW, Hurst’s The Heart.New York, NY: McGraw-Hill, 1998:1867–74. 936. Cobanoglu A, Fessler CL, Guvendik L, Grunkemeier G, Starr A.Aortic valve replacement with the Starr-Edwards prosthesis: acomparison of the first and second decades of follow-up. AnnThorac Surg 1988;45:248 –52. 937. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valveprostheses. Circulation 1994;89:635– 41. 938. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboliearly after bioprosthetic cardiac valve replacement. J Am CollCardiol 1995;25:1111–9. 939. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ,Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy inpatients with mechanical heart valves. N Engl J Med 1995;333:11–7. 940. Butchart EG, Lewis PA, Grunkemeier GL, Kulatilake N, BreckenridgeIM. Low risk of thrombosis and serious embolic eventsdespite low-intensity anticoagulation: experience with 1,004Medtronic Hall valves. Circulation 1988;78:I66 –77. 941. Saour JN, Sieck JO, Mamo LA, Gallus AS. Trial of differentintensities of anticoagulation in patients with prosthetic heart valves.N Engl J Med 1990;322:428 –32. 942. Vogt S, Hoffmann A, Roth J, et al. Heart valve replacement withthe BjorkShiley and St Jude Medical prostheses: a randomizedcomparison in 178 patients. Eur Heart J 1990;11:583–91. 943. Butchart EG, Lewis PA, Bethel JA, Breckenridge IM. Adjustinganticoagulation to prosthesis thrombogenicity and patient riskfactors: recommendations for the Medtronic Hall valve. Circulation1991;84:III61–9. 944. Horstkotte D, Schulte H, Bircks W, Strauer B. Unexpected findingsconcerning thromboembolic complications and anticoagulation aftercomplete 10 year follow up of patients with St. Jude Medicalprostheses. J Heart Valve Dis 1993;2:291–301. 945. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Lower intensityanticoagulation therapy results in lower complication rates with theSt. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994;107:1136–45. 946. Jegaden O, Eker A, Delahaye F, et al. Thromboembolic risk andlate survival after mitral valve replacement with the St. Jude Medicalvalve. Ann Thorac Surg 1994;58:1721– 8. 947. Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomizedcomparison of low-dose versus standard-dose anticoagulation inpatients with mechanical prosthetic heart valves. Circulation 1996;94:2107–12. 948. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG. Antithrombotictherapy in patients with mechanical and biological prostheticheart valves. Chest 2001;119:220S–7S. 949. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ,Konstam MA. Warfarin anticoagulation and survival: a cohortanalysis from the Studies of Left Ventricular Dysfunction. J AmColl Cardiol 1998;31:749 –53. 950. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of thelowest effective intensity of prophylactic anticoagulation for patientswith nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540–6. 951. Altman R, Rouvier J, Gurfinkel E, et al. Comparison of two levelsof anticoagulant therapy in patients with substitute heart valves.J Thorac Cardiovasc Surg 1991;101:427–31. 952. Albertal J, Sutton M, Pereyra D, et al. Experience with moderateintensity anticoagulation and aspirin after mechanical valve replacement:a retrospective, non-randomized study. J Heart Valve Dis1993;2:302–7. 953. Hayashi J, Nakazawa S, Oguma F, Miyamura H, Eguchi S.Combined warfarin and antiplatelet therapy after St. Jude Medicalvalve replacement for mitral valve disease. J Am Coll Cardiol1994;23:672–7. 954. Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J. Efficacyand safety of combined anticoagulant and antiplatelet therapy versusanticoagulant monotherapy after mechanical heart-valve replacement:a metaanalysis. Am Heart J 1995;130:547–52. 955. Thrombosis prevention trial: randomised trial of low-intensity oralanticoagulation with warfarin and low-dose aspirin in the primaryprevention of ischaemic heart disease in men at increased risk: theMedical Research Council’s General Practice Research Framework.Lancet 1998;351:233– 41. 956. Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G.Aspirin and other platelet-active drugs: the relationship amongdose, effectiveness, and side effects. Chest 1995;108:247S–57S. 957. Turpie AGG. Antithrombotic therapy after heart valve replacement.In: Yusuf S, Carne J, Camm J, Fallon E, Gersh B, EvidenceBased Cardiology. London, UK: BMJ Publishing Books, 1998;108:905–11. 958. Altman R, Boullon F, Rouvier J, Raca R, de la Fuente L, FavaloroR. Aspirin and prophylaxis of thromboembolic complications inpatients with substitute heart valves. J Thorac Cardiovasc Surg1976;72:127–9. 959. Dale J, Myhre E, Storstein O, Stormorken H, Efskind L. Preventionof arterial thromboembolism with acetylsalicylic acid: a controlledclinical study in patients with aortic ball valves. Am Heart J1977;94:101–11. 960. Chesebro JH, Fuster V, Elveback LR, et al. Trial of combinedwarfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.Am J Cardiol 1983;51:1537– 41. 961. Turpie AG, Gunstensen J, Hirsh J, Nelson H, Gent M. Randomisedcomparison of two intensities of oral anticoagulant therapy aftertissue heart valve replacement. Lancet 1988;1:1242–5. 962. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction ofexcessive anticoagulation with low-dose oral vitamin K1. AnnIntern Med 1997;126:959–62. 963. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. Thepharmacology and management of the vitamin K antagonists: the Seventh ACCP 346 347 Conference on Antithrombotic and ThrombolyticTherapy. Chest 2004; 126:204S–33S. 964. Yiu KH, Siu CW, Jim MH, et al. Comparison of the efficacy andsafety profiles of intravenous vitamin K and fresh frozen plasma astreatment of warfarinrelated over-anticoagulation in patients with mechanical heart valves. Am J Cardiol 2006;97:409 –11. 965. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound aftercessation of oral anticoagulant therapy: the biochemical evidence.Br J Haematol 1996;92:479–85. 966. Eckman MH, Beshansky JR, Durand-Zaleski I, Levine HJ, PaukerSG. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves: does low risk mean high cost? JAMA1990;263:1513–21. 967. Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinicaloutcomes associated with low-molecular-weight heparin vs unfractionatedheparin for perioperative bridging in patients receivinglong-term oral anticoagulant therapy. Chest 2004;125:1642–50. 968. Kearon C, Hirsh J. Management of anticoagulation before and afterelective surgery. N Engl J Med 1997;336:1506 –11. 969. Bryan AJ, Butchart EG. Prosthetic heart valves and anticoagulantmanagement during non-cardiac surgery. Br J Surg 1995;82:577– 8. 970. Busuttil WJ, Fabri BM. The management of anticoagulation inpatients with prosthetic heart valves undergoing non-cardiac operations.Postgrad Med J 1995;71:390 –2. 971. Tinker JH, Tarhan S. Discontinuing anticoagulant therapy insurgical patients with cardiac valve prostheses: observations in 180operations. JAMA 1978;239:738 –9. 972. Moreno-Cabral RJ, McNamara JJ, Mamiya RT, Brainard SC,Chung GK. Acute thrombotic obstruction with Bjork-Shiley valves:diagnostic and surgical considerations. J Thorac Cardiovasc Surg1978;75:321–30. 973. Copans H, Lakier JB, Kinsley RH, Colsen PR, Fritz VU, BarlowJB. Thrombosed Bjork-Shiley mitral prostheses. Circulation 1980;61:169 –74. 974. Kontos GJ Jr, Schaff HV. Thrombotic occlusion of a prostheticheart valve: diagnosis and management. Mayo Clin Proc 1985;60:118–22. 975. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study ofbridging therapy with low-molecular-weight heparin for patients atrisk of arterial embolism who require temporary interruption ofwarfarin. Circulation 2004;110: 1658–63. 976. Morton MJ, McAnulty JH, Rahimtoola SH, Ahuja N. Risks andbenefits of postoperative cardiac catheterization in patients with ballvalve prostheses. Am J Cardiol 1977;40:870 –5. 977. Shapira Y, Herz I, Vaturi M, et al. Thrombolysis is an effective andsafe therapy in stuck bileaflet mitral valves in the absence ofhigh-risk thrombi. J Am Coll Cardiol 2000;35:1874–80. 978. Ozkan M, Kaymaz C, Kirma C, et al. Intravenous thrombolytictreatment of mechanical prosthetic valve thrombosis: a study usingserial transesophageal echocardiography. J Am Coll Cardiol 2000;35:1881–9. 979. Tong AT, Roudaut R, Ozkan M, et al. Transesophageal echocardiographyimproves risk assessment of thrombolysis of prostheticvalve thrombosis: results of the international PRO-TEE registry.J Am Coll Cardiol 2004;43:77– 84. 348 979 а. Dzavik V, Cohen G, Chan KL. Role of transesophageal echocardiographyin the diagnosis and management of prosthetic valvethrombosis. J Am Coll Cardiol 1991;18:1829 –33. 980. Gueret P, Vignon P, Fournier P, et al. Transesophageal echocardiographyfor the diagnosis and management of nonobstructivethrombosis of mechanical mitral valve prosthesis. Circulation 1995;91:103–10. 981. Barbetseas J, Nagueh SF, Pitsavos C, Toutouzas PK, QuinonesMA, Zoghbi WA. Differentiating thrombus from pannus formationin obstructed mechanical prosthetic valves: an evaluation of clinical,transthoracic and transesophageal echocardiographic parameters.J Am Coll Cardiol 1998;32:1410 –7. 982. Birdi I, Angelini GD, Bryan AJ. Thrombolytic therapy for left sidedprosthetic heart valve thrombosis. J Heart Valve Dis 1995;4:154 –9. 983. Horstkotte D, Burckhardt D. Prosthetic valve thrombosis. J HeartValve Dis 1995;4:141–53. 984. Hurrell DG, Schaff HV, Tajik A. Thrombolytic therapy forobstruction of mechanical prosthetic valves. Mayo Clin Proc 1996;71:605–13. 985. Lengyel M, Fuster V, Keltai M, et al. Guidelines for managementof left-sided prosthetic valve thrombosis: a role for thrombolytictherapy: Consensus Conference on Prosthetic Valve Thrombosis.J Am Coll Cardiol 1997;30:1521– 6. 986. Gupta D, Kothari SS, Bahl VK, et al. Thrombolytic therapy forprosthetic valve thrombosis: short- and long-term results. AmHeart J 2000;140:906 –16. 987. Roudaut R, Lafitte S, Roudaut MF, et al. Fibrinolysis of mechanicalprosthetic valve thrombosis: a single-center study of 127 cases. J AmColl Cardiol 2003;41:653– 8. 988. Alpert JS. The thrombosed prosthetic valve: current recommendationsbased on evidence from the literature. J Am Coll Cardiol2003;41:659–60. 989. Rahimtoola SH. Valve prosthesis-patient mismatch: an update.J Heart Valve Dis 1998;7:207–10. 990. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact ofprosthesispatient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000;36:1131– 41. 991. David TE. Is prosthesis-patient mismatch a clinically relevantentity? Circulation 2005;111:3186 –7. 992. Tasca G, Brunelli F, Cirillo M, et al. Impact of valve prosthesispatientmismatch on left ventricular mass regression following aorticvalve replacement. Ann Thorac Surg 2005;79:505–10. 993. Rahimtoola SH. Early valve replacement for preservation of ventricular function? Am J Cardiol 1977;40:472–5. 994. Jamieson WR, Janusz MT, MacNab J, Henderson C. Hemodynamic comparison of second- and third-generation stented bioprosthesesin aortic valve replacement. Ann Thorac Surg 2001;71:S282–4. 995. Milano AD, De Carlo M, Mecozzi G, et al. Clinical outcome inpatients with 19–mm and 21–mm St. Jude aortic prostheses:comparison at long-term follow-up. Ann Thorac Surg 2002;73:37–43. 996. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46 –51. 997. Diamond GA, Forrester JS. Analysis of probability as an aid in theclinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350–8. 998. Ramsdale DR, Bennett DH, Bray CL, Ward C, Beton DC,Faragher EB. Angina, coronary risk factors and coronary arterydisease in patients with valvular disease: a prospective study. EurHeart J 1984;5:716 –26. 999. Fuster V, Pearson TA, Abrams J, et al. 27th Bethesda Conference:matching the intensity of risk factor management with the hazardfor coronary disease events: September 14–15, 1995. J Am CollCardiol 1996;27:957– 047. 1000. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V.Assessment of cardiovascular risk by use of multiple-risk-factorassessment equations: a statement for healthcare professionals fromthe American Heart Association and the American College ofCardiology. Circulation 1999;100:1481–92. 1001. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FP, DelforgeMR, Carre AG. Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease. Mechanismof angina pectoris in presence of normal coronary arteries. Am J Cardiol 1981;47:199 –205. 1002. Ross RS. Right ventricular hypertension as a cause of precordialpain. Am Heart J 1961;61:134 –5. 1003. Harris CN, Kaplan MA, Parker DP, Dunne EF, Cowell HS,Ellestad MH. Aortic stenosis, angina, and coronary artery disease. Interrelations. Br Heart J 1975;37:656–61. 1004. Graboys TB, Cohn PF. The prevalence of angina pectoris andabnormal coronary arteriograms in severe aortic valvular disease. AmHeart J 1977;93:683– 6. 1005. Hancock EW. Aortic stenosis, angina pectoris, and coronary arterydisease. Am Heart J 1977;93:382–93. 1006. Morrison GW, Thomas RD, Grimmer SF, Silverton PN, SmithDR. Incidence of coronary artery disease in patients with valvular heart disease. Br Heart J 1980;44:630 –7. 1007. Crochet D, Petitier H, de Laguerenne J, et al. Aortic stenosis in adults: contribution of catheterization to the study of associated lesions. Apropos of 137 cases. Arch Mal Coeur Vaiss 1983;76:1057–64. 1008. Exadactylos N, Sugrue DD, Oakley CM. Prevalence of coronaryartery disease in patients with isolated aortic valve stenosis. BrHeart J 1984;51:121– 4. 1009. Green SJ, Pizzarello RA, Padmanabhan VT, Ong LY, Hall MH,Tortolani AJ. Relation of angina pectoris to coronary artery diseasein aortic valve stenosis. Am J Cardiol 1985;55:1063–5. 1010. Chobadi R, Wurzel M, Teplitsky I, Menkes H, Tamari I. Coronaryartery disease in patients 35 years of age or older with valvular aortic stenosis. Am J Cardiol 1989;64:811–2. 1011. Lombard JT, Selzer A. Valvular aortic stenosis: a clinical andhemodynamic profile of patients. Ann Intern Med 1987;106:292– 8. 1012. Dangas G, Khan S, Curry BH, Kini AS, Sharma SK. Anginapectoris in severe aortic stenosis. Cardiology 1999;92:1–3. 1013. Adler Y, Vaturi M, Herz I, et al. Nonobstructive aortic valvecalcification: a window to significant coronary artery disease. Atherosclerosis 2002; 161:193–7. 1014. Basta LL, Raines D, Najjar S, Kioschos JM. Clinical, haemodynamic,and coronary angiographic correlates of angina pectoris inpatients with severe aortic valve disease. Br Heart J 1975;37:150 –7. 1015. Lacy J, Goodin R, McMartin D, Masden R, Flowers N. Coronaryatherosclerosis in valvular heart disease. Ann Thorac Surg 1977;23:429–35. 350 1016. Hakki AH, Kimbiris D, Iskandrian AS, Segal BL, Mintz GS,Bemis CE. Angina pectoris and coronary artery disease in patients with severe aortic valvular disease. Am Heart J 1980;100:441–9. 1017. Saltups A. Coronary arteriography in isolated aortic and mitral valve disease. Aust N Z J Med 1982;12:494 –7. 1018. Marchant E, Pichard A, Casanegra P. Association of coronary artery disease and valvular heart disease in Chile. Clin Cardiol1983;6:352– 6. 1019. Timmermans P, Willems JL, Piessens J, De Geest H. Angina pectoris and coronary artery disease in severe aortic regurgitation.Am J Cardiol 1988;61:826 –9. 1020. Alexopoulos D, Kolovou G, Kyriakidis M, et al. Angina andcoronary artery disease in patients with aortic valve disease. Angiology1993;44:707–11. 1021. Mattina CJ, Green SJ, Tortolani AJ, et al. Frequency of angiographically significant coronary arterial narrowing in mitral stenosis.Am J Cardiol 1986;57:802–5. 1022. Chun PK, Gertz E, Davia JE, Cheitlin MD. Coronary atherosclerosis in mitral stenosis. Chest 1982;81:36–41. 1023. Gahl K, Sutton R, Pearson M, Caspari P, Lairet A, McDonald L.Mitral regurgitation in coronary heart disease. Br Heart J 1977;39:13–8. 1024. Enriquez-Sarano M, Klodas E, Garratt KN, Bailey KR, Tajik AJ,Holmes DR Jr. Secular trends in coronary atherosclerosis—analysis in patients with valvular regurgitation. N Engl J Med 1996;335:316–22. 1025. Breisblatt WM, Cerqueira M, Francis CK, Plankey M, Zaret BL,Berger HJ. Left ventricular function in ischemic mitral regurgitae135tion—a precatheterization assessment. Am Heart J 1988;115:77–82. 1026. Zeldis SM, Hamby RI, Aintablian A. The clinical and hemodynamicsignificance of mitral regurgitation in coronary artery disease.Cathet Cardiovasc Diagn 1980;6:225–32. 1027. Lin SS, Lauer MS, Asher CR, et al. Prediction of coronary artery disease in patients undergoing operations for mitral valve degeneration.J Thorac Cardiovasc Surg 2001;121:894 –901. 1028. Osbakken MD, Bove AA, Spann JF. Left ventricular regional wallmotion and velocity of shortening in chronic mitral and aortic regurgitation. Am J Cardiol 1981;47:1005–9. 1029. Kupari M, Virtanen KS, Turto H, et al. Exclusion of coronary arterydisease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol 1992;70:635– 40. 1030. Baroni M, Maffei S, Terrazzi M, Palmieri C, Paoli F, Biagini A. Mechanisms of regional ischaemic changes during dipyridamoleechocardiography in patients with severe aortic valve stenosis and normal coronary arteries. Heart 1996;75:492–7. 1031. Bailey IK, Come PC, Kelly DT, et al. Thallium-201 myocardialperfusion imaging in aortic valve stenosis. Am J Cardiol 1977;40:889–99. 1032. Huikuri HV, Korhonen UR, Ikaheimo MJ, Heikkila J, Takkunen JT. Detection of coronary artery disease by thallium imaging using a combined intravenous dipyridamole and isometric handgrip test in patients with aortic valve stenosis. Am J Cardiol 1987;59:336–40. 1033. Rask LP, Karp KH, Eriksson NP, Mooe T. Dipyridamole thallium-201 singlephoton emission tomography in aortic stenosis: genderdifferences. Eur J Nucl Med 1995;22:1155– 62. 351 1034. Samuels B, Kiat H, Friedman JD, Berman DS. Adenosine pharmacologicstress myocardial perfusion tomographic imaging inpatients with significant aortic stenosis: diagnostic efficacy andcomparison of clinical, hemodynamic and electrocardiographic variableswith 100 age-matched control subjects. J Am Coll Cardiol1995;25:99–06. 1035. Van TA. The value of myocardial perfusion imaging for diagnosingcoronary artery disease in patients with aortic valve stenosis. AdvCardiol 2002;39:61–9. 1036. Mattila S, Harjula A, Jarvinen A, Kyllonen KE, Tala P. Combinedvalve replacement and myocardial revascularization: factors influencingearly and late results. Scand J Thorac Cardiovasc Surg1984;18:49 –52. 1037. Donzeau-Gouge P, Blondeau P, Enriquez O, et al. Calcified aorticstenosis and coronary disease: apropos of 115 surgically-treated cases[in French]. Arch Mal Coeur Vaiss 1984;77:856–64. 1038. Craver JM, Weintraub WS, Jones EL, Guyton RA, Hatcher CR Jr.Predictors of mortality, complications, and length of stay in aorticvalve replacement for aortic stenosis. Circulation 1988;78:I85–I90. 1039. Stahle E, Bergstrom R, Nystrom SO, Hansson HE. Early results ofaortic valve replacement with or without concomitant coronaryartery bypass grafting. Scand J Thorac Cardiovasc Surg 1991;25:29–35. 1040. Aranki SF, Rizzo RJ, Couper GS, et al. Aortic valve replacement inthe elderly: effect of gender and coronary artery disease on operativemortality. Circulation 1993;88:II17–23. 1041. Loop FD, Phillips DF, Roy M, Taylor PC, Groves LK, Effler DB.Aortic valve replacement combined with myocardial revascularization:late clinical results and survival of surgically-treated aortic valvepatients with and without coronary artery disease. Circulation1977;55:169 –73. 1042. Macmanus Q, Grunkemeier G, Lambert L, Dietl C, Starr A. Aorticvalve replacement and aorta-coronary bypass surgery: results withperfusion of proximal and distal coronary arteries. J Thorac CardiovascSurg 1978;75:865–9. 1043. Nunley DL, Grunkemeier GL, Starr A. Aortic valve replacement with coronary bypass grafting: significant determinants of ten-year survival. J Thorac Cardiovasc Surg 1983;85:705–11. 1044. Kay PH, Nunley D, Grunkemeier GL, Garcia C, McKinley CL,Starr A. Tenyear survival following aortic valve replacement: amultivariate analysis of coronary bypass as a risk factor. J CardiovascSurg (Torino) 1986;27:494 –9. 1045. Mullany CJ, Elveback LR, Frye RL, et al. Coronary artery diseaseand its management: influence on survival in patients undergoing aortic valve replacement. J Am Coll Cardiol 1987;10:66 –72. 1046. Czar LSC, Gray RJ, Stewart ME, De Robertis M, Chaux A,Matloff JM. Reduction in sudden late death by concomitantrevascularization with aortic valve replacement. J Thorac CardiovascSurg 1988;95:390–400. 1047. Lytle BW, Cosgrove DM, Goormastic M, Loop FD. Aortic valvereplacement and coronary bypass grafting for patients with aorticstenosis and coronary artery disease: early and late results. EurHeart J 1988;9 Suppl E:143–7. 1048. Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA.The influence of coronary artery disease and bypass grafting on earlyand late survival after valve replacement for aortic stenosis. J ThoracCardiovasc Surg 1990;100:327–37. 352 1049. Iung B, Drissi MF, Michel PL, et al. Prognosis of valve replacementfor aortic stenosis with or without coexisting coronary heart disease:a comparative study. J Heart Valve Dis 1993;2:430 –9. 1050. Lytle BW, Cosgrove DM, Loop FD, et al. Replacement of aorticvalve combined with myocardial revascularization: determinants ofearly and late risk for 500 patients, 1967–1981. Circulation 1983;68:1149–62. 1051. Magovern JA, Pennock JL, Campbell DB, et al. Aortic valve replacement and combined aortic valve replacement and coronary artery bypass grafting: predicting high risk groups. J Am Coll Cardiol 1987;9:38–43. 1052. Schaff HV, Bixler TJ, Flaherty JT, et al. Identification of persistent myocardial ischemia in patients developing left ventricular dysfunction following aortic valve replacement. Surgery 1979;86:70 –7. 1053. Hwang MH, Hammermeister KE, Oprian C, et al. Preoperative identification of patients likely to have left ventricular dysfunction after aortic valve replacement. Participants in the Veterans Administration Cooperative Study on Valvular Heart Disease. Circulation 1989;80:I65–76. 1054. Roberts DL, DeWeese JA, Mahoney EB, Yu PN. Long-term survival following aortic valve replacement. Am Heart J 1976;91: 311–7. 1055. Galvin I, Mosieri J, Paneth M, Gibson D. An analysis of isolated aortic valve surgery and combined procedures in patients over 70 years of age. J Cardiovasc Surg (Torino) 1988;29:577– 81. 1056. Cha SD, Naeem SM, Maranhao V, Gooch AS. Sequential study of left ventricular function in aortic valvular stenosis. Cathet Cardiovasc Diagn 1982;8:145–54. 1057. Collins JJ Jr, Aranki SF. Management of mild aortic stenosis during coronary artery bypass graft surgery. J Card Surg 1994;9:145–7. 1058. Fiore AC, Swartz MT, Naunheim KS, et al. Management of asymptomatic mild aortic stenosis during coronary artery operations. Ann Thorac Surg 1996;61:1693–7. 1059. Hoff SJ, Merrill WH, Stewart JR, Bender HW Jr. Safety of remote aortic valve replacement after prior coronary artery bypass grafting. Ann Thorac Surg 1996;61:1689 –91. 1060. Leprince P, Tsezana R, Dorent R, et al. Reoperation for aortic valve replacement after myocardial revascularization. Arch Mal Coeur Vaiss 1996;89:335–9. 1061. Odell JA, Mullany CJ, Schaff HV, Orszulak TA, Daly RC, Morris JJ. Aortic valve replacement after previous coronary artery bypass grafting. Ann Thorac Surg 1996;62:1424 –30. 1062. Phillips BJ, Karavas AN, Aranki SF, et al. Management of mild aortic stenosis during coronary artery bypass surgery: an update, 1992–2001. J Card Surg 2003;18:507–11. 1063. Eitz T, Kleikamp G, Minami K, Gleichmann U, Korfer R. Aortic valve surgery following previous coronary artery bypass grafting: impact of calcification and leaflet movement. Int J Cardiol 1998;64: 125–30. 1064. Hochrein J, Lucke JC, Harrison JK, et al. Mortality and need for reoperation in patients with mild-to-moderate asymptomatic aortic valve disease undergoing coronary artery bypass graft alone. Am Heart J 1999;138:791–7. 1065. Hilton TC. Aortic valve replacement for patients with mild to moderate aortic stenosis undergoing coronary artery bypass surgery. Clin Cardiol 2000;23:141–7. 353 1066. Eitz T, Kleikamp G, Minami K, Korfer R. The prognostic value of calcification and impaired valve motion in combined aortic stenosis and coronary artery disease. J Heart Valve Dis 2002;11:713– 8. 1067. ACC/AHA Task Force on Practice Guidelines. Manual for ACC/AHA Guideline Writing Committees: Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines.Available at: http:// www.acc.org/qualityandscience/clinical/manual/pdfs/methodology.pdf and http://circ.ahajournals.org/manual/.Accessed June 2007. 1068. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1–148. 1069. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis prophylaxis. J Am Coll Cardiol 2008;52:676–85. 1070. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736 –54. 1071. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation 2003;108: 2015–31. 1072. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol 2008. Vol. 52, № 13. 1073. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25:267–76. 1074. Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy J Antimicrob Chemother 2006;57:1035– 42. 1075. Бокерия Л.А., Гудкова Р.Г. Болезни и врожденные аномалии системы кровообращения. – М.: НЦССХ им. А. Н. Бакулева РАМН, 2007. – 118 с. 1076. Bach DS., Radeva J I., Birnbaum H G. et al. Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving Women and Elderly Patients Behind? The Journal of Heart Valve Disease 2007;16:362-369. 1077. Bergemann R., Müller E. Economic outcomes after heart valve replacement surgery in Germany // European Heart Journal Supplements (2001) 3 (Supplement Q), Q70–Q72. 1078. Borer JS., Bonow R. Contemporary Approach to Aortic and Mitral Regurgitation.Circulation. 2003;108:2432–2438. 1079. Brown M, Palmer C, Castaigne A, De Leeuw P, Mancia G, Rosenthal T, Ruilope L: Morbidity and mortality in patients randomisedto double-blind treatment with a long-acting calcium-channelblocker or diuretic in the International Nifedipine GITSstudy: Intervention as a Goal in Hypertension Treatment (INSIGHT). The Lancet 2000, 356:366. 1080. Butany J, Ahluwalia MS, Munroe C, et al. Mechanical heart valve prostheses: identification and evaluation (erratum). Cardiovasc Pathol 2003; 12:322-44. 1080a.Butany J, Fayet C, Ahluwalia MS, et al. Biological replacement heart valves: identification and evaluation. Cardiovasc Pathol 2003;12:119-39. 1081. Butchart E., Gohlke-Barwolf C, Antunes MJ., Roger J.C. Hall, eds Heart Valve Disease: A Guide to Patient Management After Surgery. // Abingdon, Oxon, UK: Informa Healthcare; 2006. - 199. 1082. Carabello B. A. Modern Management of Mitral Stenosis. // Circulation. 2005; 112:432-437. 1083. Chikwe J; Walther A; Pepper J The Surgical Management of Mitral Valve Disease.//Br J Cardiol 11(1):42-48, 2004. 1084. Commerford P J Valvular heart disease in South Africa in 2005. // South Africa Medical Journal.- 2005, August Vol. 95, No. 8. 568-574. 1085. Freeman R.V., Otto C. M., Spectrum of Calcific Aortic Valve Disease Pathogenesis, Disease Progression, and Treatment Strategies. // Circulation. 2005;111:3316-3326. 1086. Goldbarg S H., Elmariah S, Miller M, Fuster V. Insights Into Degenerative Aortic Valve Disease. J Am Coll Cardiol 2007;Vol.50, No.13:1205-1213. 1087. Hasdai D, Lev EI, Behar S, Boyko V, Danchin N, Vahanian A, BattlerA: Acute coronary syndromes in patients with pre-existingmoderate to severe valvular disease of the heart: lessonsfrom the Euro-Heart Survey of acute coronary syndromes.Eur Heart J 2003, 24:623. 1088. Iung B, Garbarz E, Doutrelant L, et al. Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. Am J Cardiol. 2000; 85: 1308–1314. 1089. Kang D-H, Kim Jeong Hoon, Rim Ji Hye et al. Comparison of Early Surgery Versus Conventional Treatment in Asymptomatic Severe Mitral Regurgitation. // Circulation. 2009;119:797-804. 1090. Keogh B, Kinsman R. (eds): The Society of Cardiothoracic Surgeons of Great Britain and Ireland. National Adult Cardiac Surgical Database Report. 2000-2001. Dendrite Clinical Systems Ltd, 2002. 1091. Keogh B, Kinsman R. Fifth National Adult Cardiac Surgical Database Report. Society of Cardiothoracic Surgeons of Great Britain and Ireland; 2003. Available at: http://www.scts.org. Accessed June 21, 2005. 1092. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993; 21: 1220–1225. 1093. Lunga B, Baron G, Butchart EG et all A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24: 1231–1243. 1094. Mirabel M, Iung B, Baron G et all What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? // European Heart Journal 2007 28(11):1358-1365. 1095. Mykén P S. Heart Valve Replacement Surgery: 20 Years’Experience Using a Bioprosthetic Valve. Medscape Cardiology. 2006;10(1). 354 355 1096. Otto CM. Aortic stenosis – listen to the patients, look at the valve. N Engl J Med 2000; 343:652-4. 1097. Ozer O, Davutoglu V, Sari I et al. The Spectrum of Rheumatic Heart Disease in the Southeastern Anatolia Endemic Region: Results from 1,900 Patients.// The Journal of Heart Valve Disease 2009;18:68-72. 1098. Pibarot Philippe, Dumesnil Jean G. Prosthetic Heart Valves. Selection of the Optimal Prosthesis and Long-Term Management.// Circulation. 2009; 119: 1034-1048. 1099. Roaldsen MH. Demographic alteration in mitral valve surgery. Who needs surgery in Norway//Доклад 15/09/2006. 1100. Roberts WC, Ko JM, Hamilton BA. Comparison of Valve Structure, Valve Weight, and Severityof the Valve Obstruction in 1849 Patients Having IsolatedAortic Valve Replacement for Aortic Valve Stenosis (Withor Without Associated Aortic Regurgitation) Studied at 3Different Medical Centers in 2 Different Time Periods. Circulation. 2005;112:3919-3929. 1101. Roques F, Nashef S AM, Michel P and the EuroSCORE Project Group. Regional Differences in Surgical Heart Valve Disease inEurope: Comparison between Northern and Southern Subsets of the EuroSCORE Database. // The Journal of Heart Valve Disease 2003;12:1-6. 1102. Savage EB, Ferguson TB Jr, DiSesa VJ. Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg. 2003; 75: 820–825. 1103. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.// J Am CollCardiol 1997, 29:630. 1104. Supino PG, Borer JS, Yin A. The epidemiology of valvular heart disease: an emerging public health problem. Adv Cardiol. 2002;39:1–6. 1105. Thom T, Haase N, Rosamond W, et al. Heart disease and strokestatistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. //Circulation 2006; 113:e85–151. 1106. Wu Y-X, Jin R, Gao G, Grunkemeier GL, Starr A. Cost effectiveness of aortic valve replacement in the elderly: an introductory study J Thorac Cardiovasc Surg 2007;133:608-613.